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ABSTRACT 
Protein-derived cofactors are redox and catalytic centers that are generally formed 
by the posttranslational modifications of one or more amino acids. An important class of 
these cofactors are the quinones derived from tyrosine and tryptophan. Amongst redox 
proteins, it has been known till now that oxidases either contain a flavin or a 
tyrosylquinone cofactor, whereas tryptophylquinone ones are present within the 
dehydrogenases. In recent times, oxidases from a marine bacterium, Marinomonas 
mediterranea, have been shown to possess the latter. This study involves the 
characterization of two such proteins, lysine-ε-oxidase (LodA) and glycine oxidase 
(GoxA). They have been reported to contain the same cysteine tryptophylquinone (CTQ) 
cofactor. Both require the co-expression of a second protein, LodB and GoxB respectively 
to generate matured CTQ containing active protein. Kinetic analysis of the reaction 
catalyzed by LodA showed that it followed the usual Michaelis-menten mode of interaction 
with its substrates. GoxA on the other hand exhibited allosteric cooperativity for its 
substrate glycine. This was attributed to the dimeric conformation of the wildtype GoxA 
based on size exclusion chromatographic studies. Mutagenesis study of amino acid 
residues based on the crystal structure of LodA and a homology model of GoxA, have 
given a detailed idea about their structure-function relationship. Kinetic studies on 
mutants of Tyr211 of LodA along with Lys530 present at the substrate channel, showed 
effects on both Km for the substrates and kcat for the reaction. As a result these residues 
have shown their involvement in forming a gate-like structure to control the to and fro 
movement of the substrate and products. Corresponding to this residue, the Phe237 of 
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GoxA has proved to be important in maintaining the allostericity, by mediating the stable 
dimer formation. From the kinetic parameters, Cys448 of LodA was found to be 
responsible for substrate specificity and affinity. Whereas, mutants of His466 of GoxA that 
correspond to the Cys448 residue, were unable to yield CTQ containing active GoxA. On 
the other hand, Asp512 of LodA and Asp547 of GoxA that correspond to each other, have 
been implicated for their involvement in CTQ biogenesis. This study therefore highlights 
how even though this new pool of enzymes have great degrees of similarity in terms of 
the cofactors and conserved active site residues, there are major differences in the 
mechanism of the reaction that they catalyze which on a broader sense could influence 
the overall physiological importance of the enzyme in the biological system. 
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CHAPTER 1: GENERAL INTRODUCTION 
Oxidases and dehydrogenases belong to the oxidoreductase group of redox 
enzymes. They are involved in catalyzing the transfer of electrons between different 
substances in these redox reactions1. The basic difference between an oxidase and a 
dehydrogenase lies in the type of the final electron acceptor they use in the reactions 
catalyzed by them. Oxidases as per the name, use O2 whereas dehydrogenases use 
molecules such as NAD+ 2 or other redox proteins to accept their electrons. Since redox 
enzymes are of great importance in various biological pathways such as respiration and 
metabolism3, studying different proteins of this category is of utmost importance. 
Most of these redox proteins and enzymes have cofactors that act as the redox 
active centers. Protein cofactors can be of different types. There are the inorganic ions 
such as Zn, Mg, Cu, Fe which are readily found in metalloproteins. The organic cofactors 
include the NAD, FAD (Flavin Adenine dinucleotide) and FMN (Flavin mononucleotide). 
Most of these cofactors can be easily detected by Uv/Vis spectroscopy. The latter two are 
generally found in flavoproteins. For e.g. changes in the absorbance spectrum of FAD 
around 450 nm indicates the oxidation state of the Flavin containing proteins4.  The other 
class of cofactors include the ones that have been generated by posttranslational 
modification of already existing amino acids. In recent years a lot of interesting research 
has been done on this and continues to be a growing area for more investigations. Certain 
amino acids especially the aromatic ones undergo post translational modification and 
further crosslink to adjacent amino acids to generate redox active centers. The earliest 
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known form of such cofactors was that of pyrroloquinoline quinone (PQQ) and proteins 
containing these cofactors were specifically called quinoproteins5.  From the data 
available it has been observed that the tryptophan derived cofactors are generally present 
in dehydrogenases for e.g. MADH containing TTQ. Oxidases that are quinoproteins 
generally contain tyrosine derived cofactors, for e.g. amine oxidase containing TPQ6.  
It is known that L-amino acid oxidases are generally flavoproteins containing 
Flavin-derived cofactors7. For the first time an oxidase was discovered from a marine 
melanogenic bacteria, Marinomonas mediterranea, which showed lysine-ε-oxidase 
activity8. The unique property of this enzyme is that it contained a posttranslationally 
modified tryptophylquinone cofactor, CTQ, just like a dehydrogenase, but enzymatically 
behaved as an oxidase. This protein was named LodA and was encoded by the lodA 
gene. The only other reported example of a CTQ containing enzyme was a 
dehydrogenase called quinohemoprotein amine dehydrogenase (QHNDH)9. Due to 
complexity in its structure QHNDH wasn’t studied completely. LodA was found to catalyze 
the oxidative deamination of L-lysine generating hydrogen peroxide that made it 
antimicrobial in nature10. Hence this was an interesting protein to study to understand 
how even though it contained an intrinsic property of a dehydrogenase (i.e. CTQ), it still 
managed to behave as an oxidase.     
In this study the mechanism of action has been studied. To understand the 
significance and importance of the enzyme, the elucidation of the reaction mechanism 
was necessary, as it is the presence of the CTQ that makes the enzyme active. Precursor 
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forms of the enzyme without the CTQ were found to be inactive11. From the data obtained 
it has been shown that LodA carries out the oxidative deamination by following a ping-
pong mechanism12 and occurs via the formation of a Schiff base intermediate. Its 
reductive half reaction resembles those of all other tryptophylquinone containing 
dehydrogenases and tyrosyl quinone containing oxidase. Yet it is different from both of 
these categories of redox proteins. To further characterize this and understand the 
structure-function relationship, site-directed mutagenesis was done. Cys516 and Trp581 
were involved in the CTQ formation. These were mutated to Alanine. None of the variants 
produced any active protein and no CTQ was detected in any of those mutants. Various 
possible significant residues were mutated like the Cys448, Tyr211 and Lys530 to see 
their effects on both structure and function of LodA13. Cys448 was found to be involved 
in the determining the substrate specificity and binding especially for lysine. An aromatic 
amino acid was required at the 211 position (Tyr211) which along with the Lys530 formed 
a hydrophobic pocket as they Hydrogen (H) bonded with each other. This affected the 
entry and exit of products and intermediates hence modulating the reaction rate and 
affinities for both O2 and L-lysine. 
On further genome analysis it was seen that 2 other genes from the same bacteria 
were found to encode LodA-like proteins14. This led one to believe that there is a whole 
reservoir of such oxidases that contain trytophylquinone cofactors. Amongst the two, one 
of them showed glycine oxidase activity14 and was named as GoxA. This was first 
discovered in Marinomonas mediterranea and was then recombinantly expressed in 
E.coli. It was found to be inactive in the precursor form that was devoid of a mature CTQ 
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11.  In this study we further characterize GoxA and try to elucidate the structure-function 
relationship. Since this was similar to LodA, it was thought that probably the mode of 
reaction mechanism was the same with the major difference being in the substrate which 
is Glycine for Gox. Hence kinetic analysis of the enzyme for the oxidative deamination of 
glycine was studied. This enzyme showed allosteric cooperativity for glycine which was 
absolutely unique and different from LodA. The dimeric form of the enzyme was thought 
to support this mode of reaction. Presence of glycine facilitates the binding of substrate 
at the other subunits thus increasing the overall reaction rate since the enzyme shows 
positive cooperativity. The fact that it showed an allosteric mechanism could mean that 
this has more metabolic function than antimicrobial as in the case of LodA. The crystal 
structure of GoxA has not yet been determined. This poses a problem in general to study 
any type of enzymes it terms of their structure-function. So its homology model was 
created with LodA as the reference and site directed mutagenesis was done. Residue 
His466 was analogous to Cys448 and Phe237 was analogous to Tyr211. H466 was found 
to be directly or indirectly involved in the CTQ biosynthesis because mutating this residue 
generated inactive precursor protein. On the other hand mutation of F237 resulted in the 
loss of cooperativity for glycine by forming weaker dimer with the subunits. This study 
therefore shows how apparently similar enzymes have different mechanism of catalyzing 
reactions and how just from this mechanism one can predict the overall physiological 
function of the enzyme. 
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CHAPTER 2: LITERATURE REVIEW 
Cofactors of a protein 
Cofactors are known to be molecules associated with proteins that make a protein 
active. In the absence of these cofactors proteins are still in their precursor form and are 
inactive in nature. A lot of the functional groups present in a protein may account for some 
of the catalysis, nucleophilic and electrophilic reactions but cannot account for the 
catalysis of many other enzymatic reactions. It is here that the presence of cofactors 
becomes very important. An inactive enzyme without the cofactor has been termed as 
the apoenzyme and the entire active protein has been named as the holoenzyme 15. The 
cofactors are not only involved in accelerating the reaction rate of the catalyzed reaction 
but later studies also showed the involvement of cofactors in protein folding and protein 
stability 16. According to these studies, the cofactor was found to be involved in stabilizing 
the native protein. This was possible by the interaction of the cofactor with unfolded 
polypeptide. Often this interaction prior to the protein folding step could speed up the 
overall folding process. Thus along with enhancing the reaction rates these cofactors 
adds diversity in the functions of the enzymes at times making them redox active centers 
or allowing the coordination with different substrates15.  
There are mainly 4 different types of cofactors. There are the metalloproteins which 
contain metal ions as their primary cofactors. A large number of these metal ions have 
been found associated with protein activity. Some of them include Copper (Cu), Iron (Fe), 
Zinc (Zn), Magnesium (Mg), Cobalt (Co), Molybdenum (Mo)17. The second category of 
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cofactors are the organic ones which since they are directly involved in enzymatic 
reactions hence could also be termed as coenzymes. The most common example for 
coenzymes are the FAD, NAD+ 2. Another category of cofactors are the organometallic 
ones. These have metal ions tightly associated to the organic moieties in the protein and 
cannot be dissociated from it easily. The most common example for this is heme that 
contains Fe associated to a porphyrin ring. The final category of cofactors are the ones 
that have been generated by the posttranslational modification of amino acid residues in 
proteins. Some of these are self-generated and some require the presence of other 
proteins to catalyze the biosynthesis of the cofactors6. Examples of some of these 
cofactors include tryptophylquinone cofactors that have been formed from modifications 
in tryptophan residues18. In general many of these cofactors have spectroscopic UV/Vis 
and fluorescence properties and protein cofactor interactions may influence these 
properties. If these cofactors are present at the active site of the enzyme then its 
interaction with the protein is thought to influence the enzyme kinetics and thus the steady 
state analysis is a good tool to study any such interactions. If the protein is a redox protein 
then the presence of these cofactors often influence the redox potentials and thus doing 
redox titrations can give one a good understanding of its affects19.  Midpoint redox 
potential values maybe affected in the presences and absence of these cofactors20, 21. 
Metal ions have also been implicated in many infectious diseases22. Hence studying 
protein-cofactor interactions is a good technique to figure out their importance. 
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 Inorganic metal ions  
Metalloproteins as the name suggests are proteins which have inorganic ions as 
cofactors. These metal ions are important in catalytically and redox active proteins since 
they often provide different oxidation states that help in redox reactions and electron 
transfer reactions. Often these metals are coordinated to different amino acid side chains 
and these are pretty strong interactions such that they don’t generally leach out upon 
purification of these proteins. A large number of metal ions have been found to be present 
in the protein. These include Fe, Cu, Zn, Mg, Ni, Mn and Zn. Surrounding amino acid 
residues provide ligands for these metals which in turn tend to influence the stability and 
the reactivity of the metals. Examples of 2 intriguing redox active metals iron and copper, 
containing proteins are stated below. 
 Iron (Fe) containing proteins 
               Iron is the more abundantly available transition metal ion which when present 
as a cofactor has physiological importance. Its ability to readily undergo a transition 
between Fe (II) and Fe (III) redox state makes it indispensable15. More than one oxidation 
state of iron allows it to be readily involved in the reactions involving the transfer of 
electrons. Iron cofactors can be directly bound to the amino acid side chains or in cases 
such as the heme it might be coordinated to porphyrin rings and thus will be part of 
organometallic complexes. A common example of Fe being bound to amino acids is in 
the metalloprotein intradiol catechol dioxygenase23. This belongs to oxidoreductases and 
they incorporate dioxygen into the substrates thus carrying out the oxidative cleavage of 
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catechols. Iron also has been found to be present as a cofactor along with Copper in an 
oxidase, cytochrome c oxidase which plays a major role in oxidative phosphorylation. 
Another category of Iron containing proteins are Iron-Sulphur proteins. They contain Fe-
S clusters with more than one Fe and sulphide linkages24. These clusters have been 
found in various different metalloproteins such as the Nitrogenase, Ferredoxins, NADH 
dehydrogenase and are more commonly known for their involvement in electron transfer 
in redox reaction with some being integral part of the mitochondrial respiratory chain.  
Copper (Cu) containing proteins 
             A reason for the abundant presence of copper in proteins is its ability to exist both 
in the oxidized and reduced state. Based on its oxidation state it can either have affinity 
for thiols or thioether groups or in some cases have can coordinate with O2 or imidazole 
nitrogen groups25.  Based on the surrounding ligands and the coordination number the 
copper containing proteins are able to exhibit different chemical and spectroscopic 
properties26. Type I copper containing proteins have been termed as cupredoxins in which 
the copper is coordinated by four residues. This is the most studied type of copper 
containing proteins. Examples of this are plastocyanin and azurin. Plastocyanins are 
involved in electron transfer during photosynthesis. Azurin too is involved in electron 
transfer in bacteria. These proteins are blue in appearance and have a strong absorption 
around 600nm thus depicting the color26. Galactose oxidase which is an oxidoreductase 
involved in the reduction of galactose contains a Type II copper center27. 
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Organometallic cofactors 
             Sometimes the metal maybe tightly associated or bound to organic moieties and 
do not dissociate readily. They have been known to be involved in redox and catalytic 
reactions. Such cofactors would be referred to as the organometallic ones15. Common 
examples are heme with iron attached to the porphyrin ring and cobalamin which has 
cobalt attached to the corrin ring. Heme containing proteins are discussed below.      
Heme 
Heme is one of the more important and abundantly available organometallic cofactors, 
observed in biological systems. It consists of an iron atom present in the center of the 
porphyrin ring. Based on the substitutions and coordination, the heme group can be 
classified into different types. The most common one is the heme b. it is coordinated to 
different ligand amino acids based on the type of protein in which it is present as a 
prosthetic group. For example it is coordinated to Histidine in hemoglobin28 and 
myoglobin29. Hemoglobin as is known is the iron containing oxygen transporter present 
in the red blood cells of vertebrates whereas myoglobin does the same function but is 
present in the muscle tissues of vertebrates and most mammals. Hence the heme present 
in these two proteins aid in their overall function as the oxygen-binding proteins. Two 
other heme b containing proteins are the nitric oxide synthase30 and the cytochrome 
P45031. These have cysteine as their ligand. The other forms are the heme a and heme 
c. Cytochrome c oxidase contains heme a whereas the other c-type cytochromes such 
as bacterial diheme cytochrome c peroxidase contains heme c.  
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Organic cofactors  
             Coenzymes are organic molecules that act as cofactors and are required for the 
activity of the protein. Many of these coenzymes have been derived from vitamins B1, B2 
and B6. These organic molecules can either be covalently bound to the protein or be 
loosely bound to it thus being dissociable. Nicotinamide adenine dinucleotide (NAD+) is a 
dissociable cofactor whereas cofactors like Flavin adenine mononucleotide/dinucleotide 
(FMN, FAD) and pyridoxal phosphate (PLP) are strongly associated and cannot be 
separated until the protein gets denatured. These cofactors especially the NAD+ and the 
FAD and FMN are involved in electron transfer hence are often found in oxidases and 
dehydrogenases. These cofactors generally have characteristic binding domains in 
proteins.  
Nicotinamide adenine dinucleotide (NAD)  
It is an important coenzyme used in biological systems. It has been implicated in 
processes such as glycolysis and citric acid cycle. Due to its ability to be involved in redox 
reactions, it can exist as an oxidized form (NAD+) or as a reduced form (NADH). They 
have characteristic absorption maxima at 250 nm and 340 nm respectively. Many known 
dehydrogenases use NAD as their cofactor. Glutamate dehydrogenase for example uses 
NAD+ as its cofactor to catalyze the production of ammonia and α-ketoglutarate, based 
on the biological system and the binding affinity for the substrates. For example it has 
been found to be central in amino acid catabolism in plants32 and in mammals33 it has 
been found to be important in ammonia metabolism all of which requires the ability of the 
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protein to use NAD as its cofactor rather coenzyme. Another common example of an 
NAD+ using enzyme is the alcohol dehydrogenase which has a definite binding site for 
the cofactor and catalyzes the oxidation of ethanol. 
 
Flavin adenine dinucleotide (FAD), Flavin mononucleotide (FMN)  
These cofactors have been derived from riboflavin. FADs, like the NAD cofactors are also 
involved in redox reactions and hence can exist in the oxidized and the reduced form. 
The oxidized form of FAD shows an absorption maxima at around 450nm. Free Flavin 
also exhibits fluorescence which gets quenched as and when it binds to the proteins4. For 
most of these proteins denaturation needs to be done in order to release the tightly bound 
cofactors. Various proteins have been known to contain these cofactors. Nitric oxide 
synthase contains both the FAD and FMN in a 2:1 ratio34. The only other mammalian 
protein known to contain the same is the NADPH-cytochrome P-450 oxidoreductase in 
which the 2 are present in equimolar amounts35. Another protein called thioredoxin 
reductase, thought to be a key component of the thioredoxin system supplying hydrogen 
for reduction of ribonucleotides also contained 2 molecules of FAD per molecule of the 
protein36.   
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Cofactors generated by posttranslational modification 
              Posttranslational modification is a process which involves changes in proteins 
after the process of translation has been complete. It can involve addition or removal of 
functional groups. Some of them include phosphorylation involving the addition of a 
phosphate group, glycosylation involving the addition of a carbohydrate molecules and 
methylation involving the addition of methyl groups. Posttranslational modification occur 
on amino acid residues present at the surface or at the C or N terminal of the protein. 
Sometimes the posttranslational modifications involve cleaving off peptides to generate 
active protein. Since the modifications occur at the surface, the amino acids susceptible 
to it are easily accessible. These posttranslational modifications tend to affect different 
important biological processes such as cell signaling.  
              Within a protein or a peptide, the amino acids that are available tend to have 
limited chemical functionality in proteins. In most cases they either use already present 
cofactors or exogenous ones to help in catalysis. But some of these redox proteins in 
recent times have been discovered to have alternative methods of generating cofactors. 
They have been able to generate active and catalytic sites by carrying out 
posttranslational modifications to amino acids present within either a peptide or within a 
folded protein. Amongst some of the early reported modifications in proteins was the 
histidine decarboxylase. It was known that amino acid decarboxylases always contained 
pyridoxal phosphate (PLP) as their cofactor. But there was an exception to this which was 
found in the histidine decarboxylase. It showed the presence of a serine-derived amino-
terminal pyruvoyl group37. There have also been examples of covalent linkages 
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generated by posttranslational modifications in proteins like cytochrome c oxidases that 
have been found to crosslink tyrosine and histidine38, 39. Initially quinones, were known to 
be involved in the transfer of electrons but was not implicated in redox proteins. Recent 
crystallographic and biochemical studies have shown that some oxidoreductases have 
been able to undergo posttranslational modification to generate quinones as cofactors. 
These protein-derived cofactors are synthesized biologically by crosslink formation, 
cyclization and oxygenation of aromatic amino acids.  
 
Peptide-derived quinone cofactors 
Pyrroloquinoline quinone (PQQ) 
                   PQQ was first discovered in bacterial glucose dehydrogenase5. It was 
generated by the posttranslational modification in glutamate and tyrosine that were 
present in a precursor peptide with incorporation of the Oxygen at the Tyrosine site. 
Figure 1. shows the chemical structure of the cofactor PQQ. Subsequently PQQ was 
identified in different bacterial dehydrogenases such as methanol and glucose 
dehydrogenase40, 41and very recently in alcohol dehydrogenase in Pseudogluconobacter 
saccharoketogenes. PQQ-dependent enzymes oxidizes primary alcohols sugars and 
aldehydes42. Their presence has been widely studied in prokaryotes. Most of these PQQ 
containing redox enzymes have been found in the periplasmic space of gram negative 
bacteria. 
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Figure 1 The PQQ cofactor 
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Gene products of the pqq operon has been found to be responsible for the biosynthesis 
of the cofactor and these genes expressed PQQ in E.coli which doesn’t normally produce 
it43. PQQ can oxidize its corresponding substrates and itself get reduced to a PQQH2 form 
by NADPH, glutathione. It can undergo oxidation again to revert to its quinone state via 
the formation of superoxide radicals. PQQ has also been found in membrane-associated 
dehydrogenases hence can also transfer electrons to ubiquinones attached to the plasma 
membrane.  
           PQQ as an organic molecule has been well studied in prokaryotes but its 
biosynthesis in eukaryotes and mammalian systems has not been shown. Its importance 
in human system has been controversial but evidence has shown it to influence 
physiological and biochemical processes. PQQ isn’t synthesized in the body but humans 
are constantly being exposed to dietary sources of PQQ such as milk44, tea, green 
peppers 45. The PQQ molecule has thus been found to have different physiological 
importance46.  PQQ has been shown to promote cell proliferation by acting as growth 
factor when added to human and mouse cell cultures47. More recently PQQ dietary 
supplements have been shown to increase mitochondrial functions and biogenesis and 
an improved metabolic homeostasis48. PQQ has been shown to reduce neuronal cell 
death in experimental models of stroke and spinal cord injury49, 50. Various recent work 
also show multiple other functions such as redox activity, radical scavenging along with 
alterations and changes in the cell signaling processes51. 
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Protein-derived quinone cofactors 
               The discovery of PQQ led to the finding of other quinone cofactors that were 
derived from posttranslationally modified amino acid residues. These cofactors were 
protein-derived i.e. amino acids within the protein were modified to generate redox active 
centers. The biogenesis of some of them were autocatalytic whereas some needed the 
presence of another catalyzing enzyme to do so. The quinone cofactors that have been 
obtained by modification of tyrosines and tryptophans are the most studied ones. The 
most studied tyrosine-derived cofactors are the 2,4,5-trihydroxyphenylalanine quinone or 
TPQ (Topaquinone), found mainly in copper amine oxidases and Lysine tyrosylquinone 
(LTQ) found mainly in mammalian lysyl oxidases. There is also a tyrosine-cysteine cross-
linked cofactor found in oxidative enzymes in mammals, yeasts and fungi52. Galactose 
oxidase is known to catalyze a variety of alcohols, specifically galactose, to yield 
aldehydes and H2O2. It was shown to possess this posttranslationally generated crosslink 
between Cys and Tyr52.  
Modifications involving Tryptophan residues resulted in the generation of 
tryptophylquinone cofactors. Tryptophan tryptophylquinone (TTQ) was found in amine 
dehydrogenases such as methylamine dehydrogenase (MADH) and aromatic amine 
dehydrogenase (AADH), whereas the Cysteine tryptophylquinone (CTQ) was found in 
quinohemoprotein amine dehydrogenase (QHNDH) and of late in the oxidases, Lysine-ε-
oxidase (LodA) and Glycine oxidase (GoxA). Figure 2 shows the chemical structures of 
the different above mentioned cofactors. 
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Figure 2. Quinone cofactors that are formed by posttranslational modifications. 
                                               
CTQ is cysteine tryptophylquinone. TTQ is tryptophan tryptophylquinone. TPQ is 2,4,5-
trihydroxyphenylalanine quinone or topaquinone. LTQ is lysine tryptophylquinone. 
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Tyrosylquinone cofactors 
Topaquinone (TPQ): Most copper-containing amine oxidases were initially were thought 
to contain pyridoxal phosphate PLP or PQQ. The discovery of TPQ and its extensive 
characterization indicates the importance of such redox cofactors in the proteins. TPQ is 
a ubiquitous cofactor that has spans over yeast, bacteria and mammals. The TPQ 
containing enzymes have a wide range of functions, in bacteria it could be involved in 
metabolism and in humans it could be involved in inflammatory responses. Based on the 
different organs from which it has been isolated, TPQ containing enzymes have been 
given various names. They include plasma amine oxidase, histamine oxidase, retinal 
amine oxidase. The most studied TPQ containing enzyme has been the Copper amine 
oxidase which was first discovered from bovine serum53.  
            TPQ is formed by posttranslational modifications in a tyrosine that was found in a 
consensus site sequence of Asn-Tyr (TPQ)-Asp/Glu-Tyr54. It has been confirmed that the 
synthesis of TPQ is autocatalytic in nature and is not catalyzed by another protein. Instead 
an active site Copper ion present in close proximity to the Tyrosine in the TPQ, was found 
to play an important part55. The holoenzyme with a completely synthesized TPQ shows 
an absorption maxima at 480 nm. When the amine oxidases were synthesized in a metal-
free media there was no such peak maxima, instead it just had a Tyr at the TPQ position55, 
56.  
 
19 
 
 
 
Figure 3 Proposed mechanism for TPQ biosynthesis57 
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These TPQ containing oxidases have dual functions catalyzing both their own cofactor 
synthesis and also substrate amine oxidation.  
Figure 3 shows the mechanism of TPQ biogenesis in copper amine oxidase (CAO). The 
copper amine oxidase active site is buried deep and contains a type 2 Cu(II) ion that is 
bound in position by the imidazole groups of 3 His residues at a distance of around 2Å58.  
In case of this oxidase the synthesis takes place in presence of Cu bound to conserved 
His and other surrounding amino acids59, 60. O2 reacts with the modified Tyr which gets 
deprotonated by nearby amino acids and results in the formation of dopaquinone61. There 
is a charge transfer complex formation between Cu2+ and tyrosinate and generation of a 
Cu+-tyrosyl radical species. O2 reacts with the intermediate to yield superoxide and reacts 
with tyrosine to yield the dopaquinone. Following this there is a conformational change 
which allows hydroxide to be added to it. Then the second O2 molecule oxidizes it to form 
the mature TPQ62. The copper remains bound at the site and helps in the catalysis. 
            Once the TPQ has been synthesized, the TPQ containing enzymes carry out the 
oxidation of amines via the formation of a Schiff base. This is then followed by hydrolysis 
and release of the aldehyde to produce aminoquinol63, 64. The reaction mechanism is a 
ping-pong one. The oxidative half reaction is mediated by Cu and O2 by which the 
aminoquinol reoxidizes to TPQ, releasing NH3 and H2O2. In humans CAOs can be found 
indifferent organs and tissues such as kidney, retina and blood and is known to be 
involved in cell signaling process by peroxide production65. Aberrant expression of CAO 
may lead to congestive heart failure and diabetic complications by oxidative stress on 
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microvascular system66. Hence the extensive characterization of the protein and its 
cofactor was essential. 
 
Lysine tyrosylquinone (LTQ): The lysine tyrosylquinone (LTQ) is the other tyrosine-
derived cofactor that has been studied. LTQ has been found as being an intrinsic part of 
a mammalian enzyme, lysyl oxidase, being monomeric and extracellular in nature. The 
enzyme catalyzes the posttranslational cross linking of elastin and collagen to form 
connective tissues. It uses peptidyl lysine (i.e. lysyl residues) as its substrate and oxidizes 
the residues to peptidyl-α-aminoadipic-δ-semialdehyde residues67. Lysyl oxidase is 
synthesized as an initial 50kDa precursor protein which then undergoes proteolytic 
cleavage to yield the catalytically active 32kDa68. This oxidase was found to be implicated 
in cell proliferation and tumor suppression69 and the propeptide region before the 
cleavage was thought to be responsible for this70. 
              The limitation in studying the LTQ was the low level of expression of the protein 
and the unavailability of crystal structures.  Hence using techniques like mutagenesis and 
Resonance Raman spectroscopy, Tyr 349 and Lysine 314 was found to be involved in 
LTQ formation71. Just like TPQ, the process of LTQ formation is also autocatalytic and 
doesn’t require another protein to catalyze it72. The UV/Vis spectroscopy showed that 
LTQ had an absorption maximum at 510 nm and this was 20-30 nm red shifted to TPQ 
containing CAOs71. A synthetic model for LTQ, NHR-LTQ displayed a maximum at 504 
nm which was in excellent accordance with the native enzyme. Since copper was present 
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in the active site of this LTQ enzyme, its biogenesis was thought to be similar to that of 
TPQ. The biogenesis occurred via the formation of dopaquinone followed by a 
nucleophilic attack by the ε-amino group of the lysine. The fact that Cu (II) and molecular 
O2 were essential for the biosynthesis of LTQ was shown by the isolation of copper 
depleted form of lysyl oxidase72. An exception to this is the discovery of a lysyl oxidase 
from Pichia pastoris73. Instead of having an LTQ this had a topaquinone. It was shown 
that this lysyl oxidase had similar substrate specificity like the mammalian enzyme thus 
concluding that the quinone cofactors were not responsible for substrate specificity. 
Hence even though the mechanism of its biogenesis has been studied a detailed 
investigation into the same remains to be done based on better expression systems for 
the proteins. 
Tryptophylquinone cofactors 
           The tryptophylquinone cofactor is formed by modifications at the Trp residue by 
addition of Oxygen forming quinones and crosslinking with other amino acids. The two 
known examples are the Tryptophan tryptophylquinone (TTQ) cofactor where it crosslinks 
to another Trytophan residue and the Cysteine tryptophylquinone (CTQ) where it 
crosslinks to another Cysteine residue. These tryptophylquinone cofactor containing 
enzymes were in the past known to be present only in soluble enzymes that were 
localized in the periplasmic space of gram negative bacteria. Unlike most of the 
dehydrogenases these do not use NAD+ or NADP+ as electron acceptors. Instead they 
use specific redox proteins as electron acceptors74. Methylamine dehydrogenase 
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(MADH) and aromatic amine dehydrogenase (AADH) contain TTQ and quinohemoprotein 
amine dehydrogenase (QHNDH) contains CTQ. In recent years 2 other quinoprotein 
oxidases from Marinomonas mediterranea were found to contain CTQ, Lysine-ε-oxidase 
(LodA) and Glycine oxidase (GoxA). 
 
Tryptophan tryptophylquinone (TTQ) cofactor:  
Methylamine dehydrogenase (MADH): MADH was the first known enzyme that was 
found to contain TTQ75, 76. TTQ is a posttranlationally modified protein-derived cofactor 
that is present as a prosthetic group77. MADH is a periplasmic protein which is known to 
catalyze the oxidative deamination of methylamine to yield formaldehyde and ammonia 
with transfer of electrons to another redox protein called amicyanin78. The only difference 
with the aromatic amine dehydrogenase (AADH)79 is that instead of amicyanin, it is 
another type 1 copper protein, azurin, that acts as the electron acceptor80. These 
enzymes exist in several bacteria and allow them to use amines as a source of carbon, 
nitrogen and energy. MADH uses methylamine as its substrate and the reductive reaction 
begins by an adduct formation between the TTQ and amine substrate. The aminoquinol 
is then oxidized by electron transfer to amicyanin, via the production of 
aminosemiquinone then to the oxidized TTQ by releasing ammonia81, 82. It has been 
possible to detect the different oxidation states of TTQ. The fully oxidized TTQ shows an 
absorption maxima at 440 nm, the one electron reduced semiquinone has an absorption 
maxima at 428 nm and the fully reduced quinol is at 330 nm83. 
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             MADH from P.denitrificans was present as a quaternary structure with 2α 
subunits of 41.5 kDa each and 2β subunits of 14.4 kDa each, assembled together84. The 
β-subunits have the matured TTQ. The mau operon containing mau genes, mauB and 
mauA encode the α and the β subunit respectively85 and mau C encodes for amicyanin. 
It has been found that the biosynthesis of TTQ is based on the expression of MauG 
protein encoded by the mauG gene86. In the absence of MauG a precursor form MADH 
was expressed which was called preMADH with just a single –OH group on the βTrp57 
without any crosslink to βTrp10887. Crystal structure of the complex of purified MauG with 
preMADH has been established in vitro depicting the formation of mature TTQ88. Figure 
4A shows the conversion of the corresponding Trp to the matured TTQ form catalyzed by 
MauG and 4B shows the crystal structure of the complex. This is interesting as crystal 
structure of the complex could only be obtained when the 2 purified proteins were 
incubated together and not from the expression system itself.  
              The TTQ biogenesis catalyzed by MauG has been completely and very well 
characterized. MauG is a c-type diheme enzyme that catalyzes the 6-electron oxidation 
in three, 2 electron steps89. The steps involved are the crosslink formation between the 2 
Trp residues, the hydroxylation of the βTrp57 to form a quinol and then the oxidation of 
the quinol to quinone90. It is mediated by the hemes one of which is high spin (5-
coordinate) and low spin (6-coordinate) thus forming a bis-Fe-(IV) state by either O2 or 
addition of H2O291, 92. By site directed mutagenesis studies it was also found that 
conserved Trp93 between the 2 hemes allowed facile transfer of electrons between 
them91.  
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Figure 4 MauG catalyzed TTQ biosynthesis. 
 
A. shows the chemical representation of MauG catalyzing the addition of Oxygen and the 
crosslinking with Trp in presence of [O] or oxidizing equivalents. B. The crystal structure 
of the complex of MauG in pink with β-subunits of preMADH, the α-subunits are shown in 
blue. The βTrp57, β-Trp108 and the hemes are shown in black57. The PDB ID for this 
structure is 3L4M. 
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Since the dihemes are at a distance of 40 Å from the TTQ generation site, the mechanism 
took place by a hopping mechanism of electron transfer instead of electron tunneling as 
normally observed for short distances. This transfer of electrons between the heme and 
the Trp of the preMADH occurred via the Trp199 residue93, 94. Asp32 and Asp76 have 
been implicated in their involvement in the biogenesis of TTQ by preventing the proper 
alignment of the active site residues and preventing the initial hydroxylation95. 
                The other TTQ containing protein was the aromatic amine dehydrogenase 
which was first discovered in Alcaligenes faecalis, a gram negative bacteria79. Just like 
MADH, it too had 2 subunits with the TTQ being present in the smaller one. The different 
redox states of TTQ were similar to that in MADH showing similar absorption spectra for 
the 3 states. Even though MADH catalyzes the oxidative deamination of methylamine and 
the AADH does the same for aromatic amines, their overall mechanism for the reductive 
half reaction is similar. AADH was also found to react with primary aliphatic amines 
especially the long and hydrophobic ones96. 
 
Cysteine tryptophylquinone (CTQ): 
Quinohemoprotein Amine Dehydrogenase (QHNDH): CTQ was first discovered in 
quinohemoprotein amine dehydrogenase (QHNDH). It is a periplasmic protein and has 
been isolated from P. putida97 and P. denitrificans98, the latter being also common for 
MADH expression. Expression of the protein takes place in the presence of long carbon 
chain substrates such as butylamine and also benzylamine which is used up as a source 
of energy99. Based on their source, QHNDH uses either azurin or cytochrome c as its 
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electron acceptor the latter transferring electrons to cytochrome c oxidase present as a 
part of the respiratory chain100. Even though MADH and QHNDH were isolated from the 
same bacterium, they were found to have structural differences. MADH was a homodimer 
whereas the crystal structure of QHNDH established that it was a heterotrimeric protein 
with αβγ subunits9, 101. 
              The largest α subunit has 2 heme c groups and the smallest γ subunit has the 
CTQ cofactor along with additional crosslinks between three other Cys residues to the 
carboxylic acid of either a glutamate or aspartate101. The cofactor formation involves the 
Trp 43 and Cys 31 in the γ subunit102.  
            Unlike the biogenesis of TTQ, the biogenesis of CTQ has not been well-
understood due to structural complexities. An idea was that an AslB-like protein encoded 
by ORF2 was responsible for oxidizing the Trp 43 residue101. AslB is a Fe-S protein that 
is required for the oxidation of serine and cysteine residues in sulfatases103. On the other 
hand the presence of 2 heme c groups in the α-subunit resembling the MauG protein 
could also be involved. In recent years, QhpG, a Flavin dependent monooxygenase, 
encoded by the qhpG gene, has been shown to possess sequence similarity with LodB 
and could be involved in catalyzing the initial hydroxylation at the Trp residue104. Due to 
the presence of 3 redox centers and the very high extinction coefficient of the heme 
groups, it was very difficult to measure the Em values of them. It was only achieved after 
dissociating the γ subunit from the rest of the protein105. In order to aid in the 
spectroscopic characterization and the kinetic studies, a model compound of CTQ having 
the same indole-6,7-quinone skeleton with a thioether group at C-4 position was 
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synthesized106. QHNDH has been used for the bioelectrocatalytic detection of histamine 
using its native electron acceptor cytochrome c-550107. Even though the overall structure 
of MADH and QHNDH are different, there is some similarity in the Asp residues at the 
active site that are conserved. Asp 33 of the γ-subunit of QHNDH corresponds to the Asp 
76 of the MADH β-subunit. The Asp 13 of the γ subunit of QHNDH corresponds to the 
Asp 32 of the MADH. 
             Hence amongst the known tryptophylquinone cofactors, CTQ hasn’t been 
characterized completely. Its mechanism of biogenesis and catalysis hasn’t been 
elucidated completely. In this study the characterization of structural and functional 
relationship in 2 unique tryptophylquinone cofactor containing oxidases have been 
elucidated. 
 
 Lyinse-ε-oxidase (LodA): All previous amino acid oxidase have been known to be 
flavoproteins108 and catalyze the oxidative deamination of amino acids to generate α-keto 
acids, ammonia and hydrogen peroxide. The amino acid oxidation takes place at the α-
position of the amino acid chain. The most characterized one are the ones from the snake 
venom109. The release of H2O2 determines the ability of the protein to execute 
antimicrobial functions110. Often peptides and proteins have been shown to have 
antimicrobial properties. In various higher organisms they act as a defense mechanism 
against pathogens111. Many of these LAOs have been found in microorganisms and their 
antimicrobial activity gives them an added advantage over competing strains112. One of 
the most studied LAO, is the L-lysine-α-oxidase113. Since L-lysine is an essential amino 
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acid that cannot be synthesized in the body, enzymes that are capable of cleaving these 
have been investigated in context of their possible application in oncology114.  
Comparative studies of LodA with the L-lysine-α-oxidase and lysl oxidase have also been 
done. L-lysine-α-oxidase is a flavoprotein. Even though it resulted in a much higher 
hydrogen peroxide generation, the Km for L-lysine was 40µM115. The kinetic parameter 
thus indicated that L-lysine-α-oxidase was not specific for L-lysine as its substrate and 
could use other amino acids as well. 
                 For the first time in a melanogenic marine bacterium, Marinomonas 
mediterranea116, an L-amino acid oxidase was found that contained a quinonic cofactor 
and not a Flavin117. It was called the Lysine-ε-oxidase, LodA. Unlike the other 
flavoproteins this did not have any FAD binding site118. It also differed from the others as 
the amino acid oxidation that it catalyzed was at the ε-position instead of the very common 
α-position. The oxidative deamination leads to the generation of a semialdehyde, 
ammonia and hydrogen peroxide. Due to the release of the latter, it has been found to be 
antimicrobial against both the gram positive and the gram negative bacteria119. LodA is 
secreted, thus helping in the differentiation and dispersal of biofilms by forming 
microcolonies due to its antimicrobial nature120. It showed much higher affinity and 
specificity for L-lysine than that shown by the L-lysine-α-oxidase. The reason for this is 
the that the available concentration of free amino acids in marine water is very low, 
therefore the Km for L-lysine has been adapted accordingly  
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A. 
 
                   B. 
  
Figure 5 Shows the crystal structure of LodA. (PDB ID 2ymw). 
A. show the whole protein as crystallized with the CTQ cofactors. B. Shows the enzyme 
active site with the Cys 516 and the Trp 581 residues. 
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Sequence analysis shows the presence of 2 ORFs in an operon-like fashion121. The first 
one which was the larger one encoded a 726 amino acid protein of a mass of around 
76kDa. This was the LodA. It was seen that Cysteine 516 and Trp 581 did undergo 
posttranslational modifications to form the CTQ cofactor. Three different crystal structures 
have been reported, PDB ID – 2YMW, 3WEU122, 3WEV. Figure 5A. shows the reported 
crystal structure for LodA and B. shows the active site with the modified CTQ cofactor. 
The second ORF which was 2bp from the stop codon of lodA, encoded a protein of 369 
amino acid and with an approximate molecular mass of 41.4kDa.This was LodB, which 
had a putative FAD binding domain123. It has been shown that LodB is absolutely required 
for the expression of the mature CTQ containing LodA124, hence indicating that the 
posttranslational modification of the Cys and the Trp residue could be an FAD-mediated 
process. 
             Until the discovery of LodA, only amine dehydrogenases were known to contain 
tyrptophylquinone cofactors. This was the first example of an oxidase showing an unusual 
cofactor. Hence crystal structure overlays were done with both MADH (TTQ containing) 
and QHNDH (CTQ containing) to see how the structures correlated. Various residues 
were found to be analogous to the active site Aspartates of MADH and QHNDH some of 
which have been shown to be involved in cofactor biogenesis and substrate specific. The 
presence of Asp 512 in LodA corresponding to the Asp 76 (MADH) and Asp 32 (QHNDH) 
shows possible conserved function in functionally different proteins. Figure 6A shows the 
overlay of MADH with LodA and the corresponding cofactor and active site residues, B. 
shows the overlay of QHNDH with LodA.  
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              B. 
 
 
 
 
Figure 6 Overlay of reported crystal structures of LodA, MADH, QHNDH. 
A. overlay of MADH and LodA with the cofactor forming and active site residues. B. 
overlay of LodA and QHNDH highlighting the same. 
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Recent genome sequencing studies on Marinomonas mediterranea showed the presence 
of 2 such similar genes which are both followed by lodB-like genes. A wider genome 
sequencing was done to get an idea about the distribution of these LodA-like proteins. It 
was found that 168 such similar genes were present in 144 different microbial genomes 
including some fungal ones. LodA-like proteins were categorized under group IA and a 
detailed look into their sequence shows the conserved Cys and Trp generating CTQ. All 
of them are oxidases and are expressed in organisms known for antimicrobial 
properties125. 
 
Glycine oxidase (GoxA): Based on the genome analysis of Marinomonas mediterranea, 
2 other genes were identified that showed similarity to lodA126. One of them was thought 
to show glycine oxidase activity and was called GoxA14. It too had another gene 
downstream and overlapping the stop codon for goxA which encodes a second LodB-like 
GoxB protein which too is a flavoprotein. This glycine oxidase contains a quinone cofactor 
formed from Cys 551 and Trp 566 determined from sequence alignments. This is different 
from all other known glycine oxidases (GO). The GO from Bacillus subtilis is a 45kDa 
flavoenzyme containing non-covalently bound FAD127. This GO was found to carry out 
the oxidative deamination of a wide range of substrates in order to form the α-keto acids. 
The GoxA discovered in the marine bacterium did not contain a Flavin cofactor and was 
specific for Glycine as its substrate.  
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Figure 7 Homology model of GoxA monomer with the highlighted Cys 551 and Trp 566 
involved in CTQ biosynthesis. 
 
 
 
 
35 
 
The crystal structure of GoxA has not been reported. But homology models have been 
constructed to give an idea about the possible protein structure. Figure 7 shows the 
homology model of GoxA with the Cys and Trp that form the cofactor.  
GoxA catalyzes the following reaction: 
Glycine + O2 + H2O → glyoxylate + NH3 + H2O2                                                             (2.1) 
It generates peroxide but it isn’t known if that is the only physiological function that it 
possess. Phylogenetic and sequence analysis done on microbial genomes have put 
GoxA in group II for the Lod-like proteins125. LodA and GoxA have been shown to possess 
22.8% identity and 34.6% identity. 
           It has been shown that in the absence of the GoxB and the LodB proteins, an 
incompletely modified CTQ is synthesized in GoxA and LodA respectively and the roles 
of the B protein are not interchangeable. The precursor protein that is generated in the 
absence of GoxB and LodB contains a single hydroxylation at the Trp residue11. and the 
mass spec of the precursor LodA shows an increase of 16 instead of 28 for a fully formed 
CTQ128. 
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CHAPTER 3: STEADY-STATE KINETIC MECHANISM OF LODA, A NOVEL 
CYSTEINE TRYPTOPHYLQUINONE- DEPENDANT OXIDASE 
FEBS Lett. 2014 Mar 3;588(5):752-6 
Introduction 
                LodA is a novel lysine-ε-oxidase which was recently found in the melanogenic 
marine bacterium, Marinomonas mediterranea129-131. This enzyme was originally called 
marinocine but is now referred to as LodA, the gene product of lodA. LodA exhibits 
antimicrobial properties in vivo that result from its production of H2O2. It is secreted to the 
external medium in the biofilms in which the bacterium resides. This causes death of a 
subpopulation of cells within the M. mediterranea biofilm that is accompanied with 
differentiation, dispersal and phenotypic variation among dispersal cells10.  
               Typical amino acid oxidases utilize a flavin cofactor for catalysis and act upon 
the α-amino group. LodA removes the ε-amino group of lysine and the recent crystal 
structure of LodA reveals that it contains a cysteine tryptophylquinone (CTQ) cofactor132. 
CTQ is a protein-derived cofactor57, which is generated by the posttranslational 
modification of cysteine 516 and tryptophan 581 of LodA. Analysis of LodA by mass 
spectrometry yields a molecular mass that is also consistent with the presence of CTQ128. 
Another protein LodB is required for the posttranslational formation of CTQ124, 128. All other 
tryptophylquinone cofactor-containing enzymes are dehydrogenases that use other redox 
proteins as their electron acceptors133; this is the first time that one has been shown to 
function as an oxidase. The best known tryptophylquinone enzymes possess tryptophan 
37 
 
tryptophylquinone (TTQ, Fig. 1) where the modified Trp is cross-linked to another Trp 
rather than a Cys77. The known TTQ enzymes are primary amine dehydrogenases57, 134. 
The one other CTQ-dependent enzyme that has been characterized is a 
quinohemoprotein amine dehydrogenase (QHNDH) which possesses two covalently 
attached hemes in addition to CTQ9, 101.  
               Another class of protein-derived cofactors that contain quinones derived from 
Tyr residues has been identified135. These possess the topaquinone (TPQ, Fig. 1) 
cofactor and are found only in primary amine oxidases. In each case, these enzymes also 
possess a tightly bound copper in the active site which is required for biogenesis of the 
cofactor and subsequently participates in catalysis. A related cofactor is lysine 
tyrosylquinone (LTQ) which is the catalytic center of mammalian lysyl oxidase71. This 
enzyme is also a lysine ε-oxidase but it acts only on lysyl residues of a protein substrate 
rather than free lysine67. Like the TPQ-dependent enzymes, lysyl oxidase also possesses 
a tightly-bound copper in the active site72. LodA is the first example of an amino acid or 
primary amine oxidase that contains neither a flavin nor a metal at its active site.  
               This paper presents a steady-state kinetic analysis of the reaction that is 
catalyzed by LodA (eq 1) to determine its steady-state reaction mechanism and kinetic 
parameters. The results are used to propose a reaction mechanism which is consistent 
with the crystal structures of a lysine-bound adduct of LodA132. 
        L-lysine + O2 + H2O → 2-aminoadipate 6-semialdehyde + NH3 + H2O          (3.1) 
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LodA is a novel lysine-ε-oxidase which possesses a cysteine tryptophylquinone cofactor. 
It is the first tryptophylquinone enzyme known to function as an oxidase. A steady-state 
kinetic analysis shows that LodA obeys a ping-pong kinetic mechanism with values of kcat 
of 0.22±0.04 s-1, Klysine of 3.2±0.5 μM and KO2 of 37.2±6.1 μM. The kcat exhibited a pH 
optimum at 7.5 while kcat/Klysine peaked at 7.0 and remained constant to pH 8.5. Alternative 
electron acceptors could not effectively substitute for O2 in the reaction. A mechanism for 
the reductive half reaction of LodA is proposed that is consistent with the ping-pong 
kinetics.  
Materials and Methods 
           Recombinant LodA was expressed in E.coli Rosetta cells which had been 
transformed with pETLODAB128 which contains lodA with an attached 6xHis tag and lodB 
which is required for the posttranslational modification of LodA that forms CTQ. The cells 
were cultured in LB media with ampicillin and chloramphenicol. Expression levels of 
active LodA are very sensitive to induction conditions and previously determined optimal 
conditions128 were followed. When the absorbance of the culture reached a value of 0.6, 
the temperature was decreased to15 ˚ C and cells were induced by addition of 1 mM IPTG. 
Cells were harvested after 2 hr and then broken by sonication in 50 mM potassium 
phosphate buffer (KPi), pH7.5. The soluble extract applied a Nickel-NTA affinity column 
and the His-tagged LodA was eluted using 100-120 mM imidazole in 50 mM KPi, pH 7.5. 
LodA was then further purified by ion exchange chromatography with DEAE cellulose in 
50 mM KPi, pH 7.5. The His-tagged LodA bound to the resin and was eluted using 180-
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270 mM NaCl in the same buffer. The protein was judged pure by SDS-PAGE and its UV-
visible absorption spectrum exhibited a broad peak centered at 400 nm with an 
absorbance at 400 nm which was about 13-fold less intense than the absorbance at 280 
nm. Methylamine dehydrogenase (MADH)136, amicyanin78 and cytochrome c-550137 were 
purified from Paracoccus denitrificans as described previously. 
              LodA activity had previously been assayed using a standard coupled assay for 
oxidases in which horseradish peroxidase (HRP) is also present and uses the H2O2 
product of the oxidase reaction to oxidize Amplex Red to resorufin which leads to a 
change in fluorescence8. This assay was modified to instead follow the change in 
absorbance associated with production of resorufin which has an extinction coefficient at 
of 54000 M-1 cm-1 at its absorbance maximum of 570 nm. The assay mixture contained 
0.05 mM Amplex Red, 0.1U/ml of HRP and 0.4 μM LodA in 50 mM KPi, pH 7.5 at 25 ˚C. 
The concentration of LodA was determined using an ε280= 125,180 M-1cm-1 which was 
calculated from its amino acid sequence138. Experiments were performed in which [lysine] 
was varied in the presence of fixed concentrations [O2] and vice versa. To vary the 
concentration of O2, an appropriate amount of a stock solution of air-saturated buffer 
([O2]=252 μM) was mixed with the reaction mixture which had been made anaerobic by 
repeated cycles of vacuum and purging with argon. The reactions were initiated by the 
addition of lysine. In order to account for a small background reaction in which Amplex 
Red is spontaneously converted to resorufin, control experiments were performed in the 
absence of LodA to determine the background rate which was subtracted from the 
experimentally-determined LodA-dependent reaction rates. The reaction was also 
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assayed by monitoring the release of the ammonia product using a coupled assay. The 
assay mixture contained 20 U/ml glutamate dehydrogenase, 5 mM α-ketoglutarate, 0.4 
μM LodA and 93.7 μM NADH in 50 mM KPi, pH 7.5 at 25 ˚C and the reactions were 
initiated by the addition of lysine. In assays to test the reactivity of artificial electron 
acceptors the assay mixture contained 0.4 μM LodA in 50 mM KPi, pH 7.5 at 25 ˚C under 
anaerobic conditions. The reaction was initiated by addition of lysine and monitored by 
the spectral change associated each electron acceptor, phenazine ethosulfate (PES) plus 
2,6-dichloroinophenol (DCIP) (ε600=21,500 M-1cm-1), ferricyanide (ε420=1,040 M-1cm-1), or 
NAD+ (ε340=6,220 M-1cm-1), amicyanin (ε595=21,500 M-1cm-1), cytochrome c-550 
(ε550=30,200 M-1cm-1). 
Results and Discussion 
Steady-state reaction mechanism and parameter 
           Steady-state assays of lysine oxidation by LodA were performed in order to 
determine the kinetic mechanism of this reaction and the kinetic parameters that describe 
this reaction. The initial rates of reaction were determined at different concentrations of 
lysine in the presence of a series of fixed concentrations of O2 (Fig. 8A). Double reciprocal 
plots of these data exhibited a series of lines which are clearly more parallel than 
intersecting, consistent with a ping-pong mechanism rather than an ordered or random 
sequential mechanism (Fig. 8B). Thus, the reaction is described by eq 2. Secondary plots 
of the intercept (1/kcat apparent) versus 1/[O2] (Fig. 8C) and intercept/slope (1/Klysine 
apparent) versus 1/[O2] (Fig. 8D) were each linear. These plots are described by eqs 3 
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and 4(), respectively. Similarly, when the initial rates of reaction were determined at 
different concentrations of O2 in the presence of a series of fixed concentrations of lysine 
a series of parallel lines was obtained in the reciprocal plots and secondary plots were 
linear (Figures 8E and 8F) and analysis yielded similar values of Kcat = 0.22 ± 0.04 s-1, Km 
for lysine is 3.2±0.5 μM, Km for O2 is 37.2±6.1 μM . 
 
 
                  kcat[lysine][O2] 
  v/E =     ———————————————————                  (3.2)                       
  
                    Klysine[O2] + KO2[lysine]  +[lysine][O2] 
 
 
 
intercept  =   (KO2/ kcat) (1/[O2]) +  (1/ kcat)                             (3.3) 
intercept/slope  =   (KO2/ Klysine) (1/[O2]) +  (1/ Klysine)        (3.4) 
This reaction was also studied using another coupled enzyme assay in which the 
rate of formation of the ammonia product was coupled to NADH oxidation by glutamate 
dehydrogenase in the presence of α-ketoglutarate. When the assay was performed using 
saturating concentrations of 100 μM lysine and 252 µM O2 the rate of reaction was 
0.25±0.07 s-1which is within experimental error of the kcat value obtained in the assay 
which monitored H2O2 production. 
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Figure 8 Steady-state kinetic analysis of LodA. 
A. Initial rates were determined at different concentrations of lysine in the presence of a 
fixed concentration of 252 (○), 129 (♦), 54 (▼), 11 (▲) or 5 (●) µM O2. B. Double reciprocal 
plot of the data shown in panel A. C. Secondary plots of the y-intercept (1/apparent kcat) 
from panel B versus 1/[O2]. Data are fit by eq 3. D. Secondary plots of the y-
intercept/slope (1/apparent Klysine) from panel B versus 1/[O2]. Data are fit by eq 4. E. 
Secondary plots of the y-intercept (1/apparent kcat) from plots of v/E versus [O2] against 
1/[lysine]. Data are fit by eq 3. F. Secondary plots of the y-intercept/slope (1/apparent 
KO2) from plots of v/E versus [O2] against 1/[lysine]. Data are fit by eq 4.Error bars are 
indicated in the secondary plots (C-F). 
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Dependence of LodA activity on pH 
   The pH dependence of kcat and kcat/Km for lysine were determined at 252 µM O2 
(Fig. 9). The kcat value exhibited a bell-shaped pH profile with a maximum at pH 7.5. This 
suggests that there are at least two residues that are required and that one must be 
protonated and the other must be unprotonated for catalysis. In contrast the kcat/Km values 
reached a maximum at pH 7.0 and stayed relatively constant up to pH 8.5. Thus, the 
catalytic efficiency of LodA is retained at the higher pH as a consequence of a decrease 
in Klysine. 
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Figure 9 Dependence on pH of kcat and kcat/Km for lysine at saturating concentration of 
O2.  
Error bars are indicated. 
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Reactivity towards alternative electron acceptors. 
The distinguishing property between an oxidase and a dehydrogenase is that, the 
oxidases use oxygen as their final electron acceptor whereas the latter use other redox 
proteins or non-protein electron acceptors other than oxygen. Since all other know 
tryptophylquinone enzymes are dehydrogenases the ability of LodA to function as a 
dehydrogenase was tested using alternative electron acceptors. The most widely used 
assay for quinoprotein dehydrogenases uses PES coupled to DCIP. For comparison the 
assay was also performed on MADH which possesses the TTQ cofactor. When assayed 
in the presence of saturating methylamine with 5 mM PES and 100 µM DCIP MADH 
exhibited a rate of 36 s-1 while LodA when assayed in the presence of saturating lysine 
under these conditions exhibited a rate of 0.06 s-1. Another commonly used artificial 
electron acceptor is ferricyanide. When similarly assayed in the presence of 1 mM 
potassium ferricyanide with saturating lysine LodA exhibited a rate of 0.10 s-1. For a more 
direct comparison of the efficiency of the artificial electron acceptors, the assays were 
repeated using 252 µM PES or ferricyanide, a concentration equivalent to that used for 
O2 (KO2 = 37.2±6.1 μM). At this concentration the rates with PES/DCIP and ferricyanide 
were each 0.01 s-1 which is barely above background, compared 0.22±0.04 s-1 for O2. 
NAD+ (1 mM) was also tested in the presence of 100 µM lysine and no detectable reaction 
was observed. Two protein electron acceptors were also tested. The copper protein 
amicyanin is the natural electron acceptor for MADH. In the steady state reaction of 
methylamine dependent amicyanin reduction by MADH, amicyanin exhibits a kcat of 48 s-
1 and Km of 6 µm139. When LodA was assayed with 100 µM amicyanin and saturating 
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lysine the rate was only 0.008 s-1. Cytochrome c-550 from P. denitrificans is a relatively 
promiscuous electron acceptor that shares structural features with many bacterial and 
mammalian cytochromes c140. When LodA was assayed with 100 µM cytochrome and 
saturating lysine the rate was 0.002 s-1. 
One cannot rule out the possibility that in vivo there is an unidentified redox-active 
molecule or protein that could serve as an electron acceptor for LodA instead of O2. 
However, no significant dehydrogenase activity of LodA could be detected in this study. 
These results support the proposal that the generation of H2O2 and consequent 
antimicrobial activity129 is the main physiological function of LodA, which is secreted from 
cell to perform this function. 
Proposed mechanism 
The ping-pong kinetic mechanism requires that an intermediate form of the 
enzyme exist after binding of substrate and release of the first product prior to binding of 
the second substrate. This finding is consistent with the reported crystal structure of LodA 
with a covalent lysine adduct with CTQ132 and suggests the following reaction mechanism 
(Fig. 10). The ε-amino group of lysine must first be deprotonated, likely by an active site 
residue, so that the resulting nucleophilic NH2 group can attack the electrophilic carbonyl 
carbon to displace the bound oxygen and yield a Schiff base intermediate, as seen in the 
crystal structure. An active site residue then abstracts a proton from the ε-carbon reducing 
the cofactor and resulting in the Schiff base now involving the ε-carbon. Inspection of the 
crystal structure of the LodA-lysine adduct132  reveals that the S of Cys448 is 
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approximately 5.5 Å from this carbon and could possibly be involved in this step. This 
covalent adduct is then hydrolyzed to release the aldehyde product prior to O2 binding. 
This yields an aminoquinol intermediate form of the enzyme consistent with a ping-pong 
mechanism. This proposed mechanism for this reductive half-reaction is essentially 
identical to those of QHNDH102 and MADH139, which possess CTQ and TTQ, respectively. 
It is also the same mechanism proposed in the reductive half-reactions of the TPQ-
dependent amine oxidases141. With the TTQ-dependent MADH it was shown that the 
ammonia product was not released until after the quinol was oxidized to the quinone by 
its electron acceptor, and that in the steady-state this occurred by displacement of the 
amino group from the cofactor by the next amine substrate molecule102. This may be true 
for LodA as well. Alternatively, it could be hydrolyzed by water. A key question which 
remains unanswered is how the quinol or aminoquinol in LodA is reoxidized by O2. In the 
TPQ-dependent oxidases Cu2+ is also present at the active site. It has been proposed 
that this interacts with the quinol intermediate to yield a Cu+-semiquinone intermediate 
which would allow reaction of the Cu+ with oxygen to generate a superoxide species in 
the first step of the reoxidation142, 143. LodA, however, does not have a bound metal. 
Future characterization of the mechanism of the oxidative half-reaction of LodA should 
be of great interest. 
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Figure 10. Proposed mechanism for LodA-catalyzed oxidative deamination of 
lysine. 
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CHAPTER 4: ROLES OF ACTIVE SITE RESIDUES IN LODA, A CYSTEINE 
TRYPTOPHYLQUINONE DEPENDENT LYSINE-Ε-OXIDASE 
Arch Biochem Biophys. 2015 Aug 1;579:26-32 
Introduction   
LodA (previously called marinocine) is an ε-lysine oxidase that was first discovered 
in Marinomonas mediterranea, a melanogenic marine bacterium8, 129, 130. It catalyzes the 
oxidative deamination of lysine by removing the ε-amino group and releasing the 
aldehyde product plus hydrogen peroxide (eq 1). When secreted out into the biofilm in 
which the bacterium resides, LodA exerts antimicrobial activity as a consequence of the 
production of H2O2. This is beneficial because causing death of a subpopulation of cells 
facilitates biofilm differentiation and dispersal of surviving cells with phenotypic variation 
among dispersed cells10. Wild type (WT) LodA has been recombinantly expressed in E. 
coli128 and isolated. LodA contains a protein-derived cofactor6 which is generated by 
posttranslational modifications. The cofactor is cysteine tryptophylquinone (CTQ) which 
is formed by the di-oxygenation of Trp581 and the crosslinking of this residue with 
Cys516. Expression of active LodA with correctly synthesized CTQ requires the co-
expression of the lodB gene128, which encodes a flavoprotein that is required for the 
posttranslational modifications that generate CTQ. 
    Lysine + O2 + H2O → 2-aminoadipate 6-semialdehyde + NH3 + H2O2           (4.1) 
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LodA is the first enzyme that was shown to use a tryptophylquinone cofactor that 
functions as an oxidase. All previously described enzymes that use CTQ or tryptophan 
tryptophylquinone (TTQ) cofactors are dehydrogenases that use other redox proteins or 
small molecules other than NAD(P)+ as electron acceptors133. LodA is distinct from the 
other known tryptophylquinone enzymes in using an amino acid as a substrate. LodA is 
also unusual among amino acid oxidases since the other enzymes previously described 
in this group utilize a flavin cofactor. Three crystal structures of LodA have been 
determined, LodA isolated from M. mediterranea alone (PDB 3WEU) and with the lysine 
substrate covalently-bound to CTQ (PDB 3WEV)132, and recombinant LodA isolated from 
E. coli (PDB 2YMW). Inspection of these structures identified the residues which are 
modified to form CTQ, Trp581 and Cys516. It was subsequently shown that mutation of 
either of these two residues to Ala resulted in no CTQ biosynthesis11. It was also shown 
that conversion of Asp512, which is in close proximity to CTQ, to Ala led to expression of 
a precursor of LodA without CTQ11. A similar effect was reported when the structurally 
analogous Asp was mutated in methylamine dehydrogenase (MADH). That led to 
expression of a precursor of MADH without TTQ95. 
 A steady-state kinetic study showed that LodA follows a ping-pong mechanism in 
which it first interacts with lysine forming a Schiff base intermediate with CTQ, then 
releases the aldehyde product, and then binds O2 to finally release NH3 and H2O212. 
(Figure 12). From the structure of LodA it was also possible to identify other residues of 
interest in the active site of LodA which could participate in binding of one or both 
substrates, or catalysis, as well as CTQ biosynthesis (Figure 11). These residues are the 
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topic of this study. Cys 448 is located in close proximity to the quinone oxygens of CTQ. 
Two other quinoproteins, the CTQ-containing quinohemoprotein amine dehydrogenase 
(QHNDH)101 and the TTQ-containing MADH144, have a structurally conserved Asp residue 
in the position corresponding to Cys448 in the LodA structure in the active site. Mutation 
of the corresponding Asp in MADH affected the efficiency of MauG-dependent TTQ 
biosynthesis but had no effect on the catalytic activity of the population of the isolated 
MADH with fully formed TTQ95. As such, Cys448 in LodA was converted to Asp, as well 
as Ala, to ascertain its role in CTQ biosynthesis or catalysis or both. Tyr211 resides in a 
loop comprised of residues 206 to 215, and it is flanked by one and three Gly residues on 
either side. This loop which is located close to the entrance of the active site was not 
visible in the crystals structures of the free and substrate bound native enzymes. In the 
structure of recombinant LodA, this loop was defined in the structure of one of the two 
molecules in the asymmetric unit but not in the other. These observations are consistent 
with mobility of this loop and a possible role in controlling substrate binding or product 
release, or both, from the active site. To probe the role of Tyr211 it was converted to Phe, 
Ala and Glu. Lys530 is of interest because it appears to form a hydrogen bond (2.7 Å) 
between its ε-amino N and the phenolic O of Tyr211. It was converted to Ala and Arg. 
The results of this study demonstrate that these residues in the active site of LodA play 
multiple roles in binding of lysine and O2, catalysis and CTQ biosynthesis. Analysis of the 
Integrated Microbial Genomes database of genome sequences identified 168 genes from 
144 different bacterial sequences that encoded LodA-like proteins125. LodA from M. 
mediterranea was classified as a member of Group IA LodA-like proteins. The residues 
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which were mutated in this study were highly conserved in these sequences. These 
results are discussed in the context of the different evolutionary factors that must be 
considered for enzymes which possess protein-derived cofactors, in which the catalytic 
cofactor must be generated by posttranslational modifications. 
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Figure 11 Residues of interest in the active site of LodA. 
A portion of the structure of LodA (PDB entry 2YMW) is shown with the residues that form 
CTQ and other residues of interest in the active site shown as sticks 
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Figure 12 Reaction mechanism for the LodA-catalyzed oxidative deamination of 
lysine. 
Represents an active-site residue which participates in acid–base chemistry 
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Materials and Methods 
 
Construction, expression and purification of recombinant proteins.  
Wild-type (WT) LodA and LodA variants that were generated by site-directed 
mutagenesis were expressed in E. coli Rosetta cells as described previously with the lodB 
gene co-expressed12, 128. The recombinant LodA possessed a 6XHis tag to facilitate 
purification as previously described12. The following LodA variants were generated by site 
directed mutagenesis: C448A, C448D, Y211A, Y211E, Y211F, K530A and K530R. The 
forward and reverse primers that were used are shown in Table 1. Most of the mutations 
were made using the QuikChange Lightning kit. The Y211A and C448A mutations were 
constructed using the overlapping extension method. In the latter case, pETLODAB15 
was used as a template for the mutagenesis PCR128 using Pfu DNA polymerase 
(Promega). The outer primers used to perform the last PCR step containing the mutations 
were MARDIRsac1 (5’-CTCTGGTGAGCTCCTACAG-3) and MAREVeco2 (5’-
GTGCTTGGGAGAATTCGCCTC-3’). After PCR amplification, fragments were cloned 
using the SacI-SacII sites in pETLODAB15, substituting the wild type copy of lodA. All 
mutations were confirmed by automated DNA sequencing. All cloning steps were 
performed using E. coli DH5α and the plasmids obtained were electroporated or 
transformed into E. coli Rosetta just before induction.   
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The concentration of purified LodA was determined using an ε280= 125,180 M-1cm-1 which 
was calculated from its amino acid sequence138.  
Steady-state kinetic analysis.  
The steady-state activity of ε-lysine oxidase was monitored using a coupled assay 
that included horseradish peroxidase (HRP), which uses the H2O2 product of the reaction 
to oxidize Amplex Red to resorufin, which has an extinction coefficient of 54000 M-1cm-1 
at 570 nm12. The assay mixture contained 0.05 mM Amplex Red, 0.1 U/ml of HRP and 
0.42 µM LodA (WT or variants) in 50 mM potassium phosphate buffer, pH 7.5, at 25 ˚C 
with the indicated amounts of lysine and O2 included. To vary [O2] the buffer was made 
anaerobic by repeated cycles of vacuum and purging argon and mixed with an 
appropriate amount of air saturated ([O2]=252 µM) or 100% O2-saturated ([O2]= 1150 µM) 
buffer145. In order to investigate the possibility that any of the mutations had converted 
LodA from an oxidase to a dehydrogenase, reactions were also performed under 
anaerobic conditions using artificial electron acceptors as described previously12. In these 
cases the reaction was initiated by addition of lysine and monitored by the spectral change 
associated each potential electron acceptor, phenezine ethosulfate (PES) plus 2,6-
dichloroinophenol (DCIP) (ε600=21,500 M-1cm-1), ferricyanide (ε420=1,040 M-1cm-1), or 
NAD+ (ε340=6,220 M-1cm-1). The data were fit by eq 2. 
                   v/E = kcat[S]/([S] + Km)       (4.2) 
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Estimation of the extent of CTQ biosynthesis.  
The absorption spectrum of the purified oxidized form of active LodA exhibits 
characteristic features in the 350-450 nm range (Figure 13A). Inspection of the absorption 
spectra of the purified variant enzymes revealed the ratio of absorbance at 400 nm to 
absorbance at 280 nm (A400/A280) was affected by some of the mutations, despite the fact 
that proteins were pure as judged by SDS-PAGE. The features of the absorption spectra 
of the variants are essentially identical to that of WT LodA except for the intensity (Figure 
13B). The most likely explanation for this is that some mutations affect the extent to which 
CTQ biosynthesis has occurred, yielding a mixed population of active LodA with mature 
CTQ and inactive preLodA with incompletely synthesized CTQ. Unfortunately, it was not 
possible to verify this by determining a molar extinction coefficient for CTQ in LodA by 
performing a spectrochemical quantitative redox titration because of poor reactivity of the 
protein-bound CTQ towards dithionite and other reductants. For ease of comparison, the 
ratio of A400/A280 for each variant is presented, normalized with the value for WT LodA set 
as 1.0 (Table 2). To be sure that the A400 was not varying due to changes in the active-
site environment that were caused by mutations, the ratio of A400/A280 was also 
determined for proteins after incubation in 6 M guanidine HCl. The values for these 
unfolded proteins were the same as for the native proteins indicating that the ratio of 
A400/A280 was a valid indicator of the extent of CTQ biosynthesis.  For determination of kcat 
values, the concentration of enzyme was determined from A280. As such one may wish to 
adjust the kcat values for variants with normalized A400/A280 values greater or less than 
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1.0. The Km values will not be affected by the variation in A400/A280 since the 
experimentally determined Km is not dependent on the concentration of the enzyme. 
 
Sequence alignments of LodA-like proteins.  
LodA-like proteins belonging to group IA, as defined previously138 includes LodA 
and the most similar proteins. The proteins in this group were aligned using the program 
clustal omega [17] available at http://www.ebi.ac.uk/Tools/msa/clustalo/. 
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     Table 1: Primers used to generate site-directed mutations 
 
 
 
 
 
 
 
Mutation Primers 
 
C488A forward  5’-GTTGGATTGCCTATGGCTCCAGGAATAGAAATG-3’ 
Reverse 5’-CATTTCTATTCCTGGAGCCATAGGCAATCCACC-3’ 
 
C448D forward: 5’ GATTGCCTATGGATCCAGGAAT 3’ 
reverse: 5’ ATTCCTGGATCCATAGGCAATC 3’ 
 
Y211A  forward 5’-CAGATCTCAGCGGTGCTGGTGGTGGAGATGA-3’ 
Reverse 5’-TCATCTCCACCACCAGCACCGCTGAGATCTG-3’ 
 
Y211E forward: 5’ GATCTCAGCGGTGAAGGTGGT 3’ 
reverse: 5’ ACCACCTTCACCGCTGAGATC 3’ 
 
Y211F forward: 5’ GATCTCAGCGGTTTTGGTGGT 3’ 
reverse: 5’ ACCACCAAAACCGCTGAGATC 3’ 
 
K530A forward: 5’ AGCGTCAATGCAGCAAGTCAG 3’ 
reverse: 5’ CTGACTTGCTGCATTGACGCT 3’ 
 
K530R forward: 5’ AGCGTCAATCGAGCAAGTCAG 3’ 
reverse: 5’ CTGACTTGCTCGATTGACGCT 3’ 
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Table 2 Steady-state kinetic parameters for LodA variants 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Normalized 
value  
of A400/A280a 
kcat (s-1)b Km lysine (µM) Km O2 (µM) 
WT LodA 1.0 0.34 ± 0.01 3.9 ± 0.2 199 ± 20 
C448A LodA 1.0 0.39 ± 0.02 48 ± 4 543 ± 94 
C448D LodA 1.5 0.29 ± 0.03  
(0.19) 
142 ± 33 386 ± 70 
 Y211F LodA 0.8 0.19 ± 0.02 
(0.23) 
129 ± 22 522 ± 162 
Y211A LodA 1.5 No reaction No reaction No reaction 
Y211E LodA 1.5 No reaction No reaction No reaction 
K530A LodA 0.7 1.2 ± 0.1 
(1.7) 
52 ± 5 1043 ± 102 
K530R LodA 0.3 0.68 ± 0.04  
(2.3) 
113 ± 13  706 ± 95  
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Figure 13 The absorbance spectra of WT LodA and LodA variants. 
A. The absorbance spectrum of WT LodA with the visible absorbance features of CTQ 
magnified in the inset. B. The visible absorbance spectra of LodA variants in this study. 
The 280 nm absorbance in each of these spectra is identical so the observed variations 
in the intensity of the absorbance reflect the variation in A400/A280 nm of these variant 
proteins. The spectra from top to bottom are C448D, Y211A, Y211E, WT, C448A, Y211F, 
K530A and K530R LodA. 
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Results  
Modification of the steady-state assay conditions to allow comparison of LodA 
variants.  
In the previous steady-state kinetic study of LodA, the maximum concentrations of 
lysine and O2 that were used were 30 µM and 252 µM, respectively12. Those values were 
well above the Km values that were determined for each substrate. Preliminary 
examination of the LodA variants which are the topic of the current study revealed that 
some of them exhibited significantly greater Km values for these substrates. In order to 
obtain reasonable estimates for the Km and kcat values for these variants, it was necessary 
to extend the range of substrate concentrations used to 1 mM for lysine and 1150 µM for 
O2 (100% O2 saturation). In the presence of 1150 µM for O2, the reaction with WT LodA 
exhibited values of kcat of 0.34 ± 0.01 s-1, Km for lysine of 3.9 ± 0.2 µM. These values of 
kcat and Km for lysine are similar to the previous reported values of 0.22 ± 0.04 s-1 and 3.2 
± 0.2 µM, respectively12. However in the presence of 1 mM for lysine, a Km for O2 of 199 
± 20 µM was obtained which is larger than the previously reported value of 37 ± 6 µM. 
The reason for this discrepancy is unclear. It may be an artifact caused by the very high 
lysine concentration which is required to study the variants.  It is possible that lysine is 
binding non-specifically to the enzyme, or perhaps competing with the other substrate 
(O2) in the ping-pong mechanism. Despite this peculiarity, in this study all LodA variants 
and WT LodA were analyzed at the higher concentration ranges so that the values of the 
kinetic parameters for each enzyme could be compared under the same conditions. 
Furthermore, as a consequence of some of the mutations, the apparent Km for O2 
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approached the [O2] in 100% O2-satuated buffer. As, such it was not possible to perform 
experiments in which [O2] could be varied over an appropriate range so as to obtain true 
kinetic parameters. As a consequence of this, the Km values that are reported here should 
be considered apparent Km values. However, as can be seen in the results which follow 
(Table 2), the effects of these mutations on kinetic parameters are quite evident and so 
the conclusions that can be drawn from these results are not compromised by these 
limitations imposed by the experimental system.  
Effects of Cys448 mutations 
Cys448 is present at the active site of LodA in close proximity (5.3 Å) to the CTQ 
cofactor. This residue was of particular interest because in the TTQ-dependent MADH, 
mutation of an Asp residue which occupies the analogous position near TTQ in the active 
site, to Asn caused decreased efficiency of TTQ biosynthesis95. C448A and C448D LodA 
mutations were made and each of these variant proteins was expressed and isolated at 
yields comparable to that of the WT LodA. The C448D LodA mutation actually increased 
the A400/A280 ratio of the purified protein. This suggests that WT LodA contains a 
subpopulation with incompletely biosynthesized CTQ and that introducing Asp at this 
position in LodA has enhanced the efficiency of CTQ biosynthesis relative to WT LodA.  
The C448A and C448D LodA variants each exhibited lysine oxidase activity 
(Figure 14, Table 2). The kcat values of 0.39 ± 0.02 s-1 for C448A LodA and 0.29 ± 0.03 s-
1 for C448D LodA are similar to that of WT LodA of 0.34 ± 0.01 s-1. Previous studies of 
LodA have indicated that an active site base is needed to deprotonate the lysine-CTQ 
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adduct during catalysis12, 132. As the Cys448 mutations do not significantly decrease kcat, 
this residue does not appear to function as an active-site base or play any direct role in 
the catalytic reaction steps. However, the Km values for both substrates were increased. 
The Km for O2 of 544 ± 94 µM for C448A LodA is about 3-fold greater than that for WT 
LodA. For C448D LodA the Km of 386 ± 70 µM is about 2-fold greater. The Km for lysine 
of 48 ± 4 µM for C448A LodA is 12-fold greater than that for WT LodA and for C448D 
LodA the Km of 142 ± 33 s-1 is 36-fold greater. These data suggest an important role for 
Cys448 in lysine binding, or more specifically, facilitating the formation of the lysine-CTQ 
adduct.  
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Figure 14 Effects of the C448A and C448D mutations on the steady-state activity of LodA. 
A.   Assays were performed in the presence of a fixed concentration of 1150 O2. B. Assays 
were performed in the presence of a fixed concentration of 1 mM lysine. The symbols 
represent WT LodA (▲), C448A LodA (■) and C448D LodA (●). The lines are fits of each 
data set to eq 1. 
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Effects of Tyr211 mutations 
Tyrosine 211 is situated on a mobile loop in proximity to the active site of LodA 
(discussed earlier). Tyr211 was mutated to Ala, Glu and Phe. In each case, the amount 
of protein expressed and isolated was similar to that of WT LodA. However, only the 
Y211F LodA exhibited activity. Interestingly the A400/A280 for the purified Y211A LodA and 
Y211E LodA were each greater than that of WT LodA and equal to that of C448D LodA 
which is the highest value observed in this study. This indicates that the lack of enzymatic 
activity of Y211A and Y211E LodA is not due to lack of CTQ biosynthesis which was not 
compromised, but apparently optimized by these mutations. In contrast to those 
mutations, Y211F LodA exhibited an A400/A280 less than that of WT LodA suggesting that 
the biosynthesis of CTQ is a bit less efficient in this variant. However, Y211F LodA was 
active (Figure 15, Table 2). The kcat value of 0.19 ± 0.02 s-1 for Y211F is similar to that of 
WT LodA of 0.34 ± 0.01 s-1, particularly when one takes into consideration the lower 
A400/A280 for Y211F LodA. The Km for lysine is 129 ± 22 µM which is 30-fold greater than 
for WT LodA. The Km of O2 is 522 ± 162 µM which is 2.7-fold greater than for WT LodA. 
These results highlight the importance of an aromatic residue at position 211 for substrate 
binding. While Y211F LodA has a near normal kcat, the affinity for each substrate is 
significantly compromised. Y211A and Y211E LodA are completely inactive, despite the 
presence of CTQ, suggesting that binding of substrates is further compromised in these 
variants to the extent that activity is undetectable. 
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Figure 15 Effects of the Y211A, K530R and K530A mutations on the steady-state activity 
of LodA. 
A. Assays were performed in the presence of a fixed concentration of 1150 O2. B. Assays 
were performed in the presence of a fixed concentration of 1 mM lysine. The symbols 
represent WT LodA (▲), K530R (▼), K530A LodA (■) and Y211F LodA (●).The lines are 
fits of each data set to eq 1. 
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Effects of Lys530 mutations 
Inspection of the one crystal structure in which Tyr211 is visible (PDB 3WEV) 
reveals that it forms a hydrogen bond with Lys530 (Figure 11). As such, this residue was 
mutated to Ala and Arg. The protein was expressed and isolated at levels comparable to 
WT LodA. However, the A400/A280 was significantly decreased indicating that the presence 
or absence of Lys530 does affect the extent of CTQ biosynthesis. While this residue is 
not that close to CTQ, it is situated on the outer side of the active site and hence could 
be involved in CTQ biosynthesis by a direct or indirect involvement with the modifying 
enzyme LodB.  
Interestingly, the mutations of Lys530 increased kcat (Table 2). For the reaction 
catalyzed by K530A LodA the kcat is 1.2 ± 0.1 s-1 which is around 3.5-fold greater than for 
WT LodA and that for K530R is 0.68 ± 0.04 s-1 which is double that of WT LodA. 
Considering the lower A400/A280 for K530A and K530R LodA, the true kcat may be even 
greater if one considers the lower level of CTQ that is present. While the kcat has been 
significantly enhanced by these mutations, the affinity for each substrate was greatly 
decreased. For K530A, the Km value for lysine is 52 ± 5 µM and that for O2 is 1043 ± 102 
µM. For K530R, the Km value for lysine is 112.5 ± 12.9 µM and that for O2 is 706.1 ± 94.8 
µM. While the affinity for O2 is significantly decreased, because of the increase in kcat, the 
kcat/Km (O2) values for K530 and K530R LodA of 1150 s-1M-1 and 960 s-1M-1 and not that 
much lower than the value for WT LodA of 1710 s-1M-1.  
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Conservation of Cys448, Tyr211 and Lys530 in sequences of proteins encoded by 
LodA-like genes 
Analysis of the Integrated Microbial Genomes database of genome sequences 
identified 168 genes from 144 different bacterial genomes that encoded LodA-like 
proteins125. LodA from M. mediterranea was classified as a member of Group IA LodA-
like proteins. Alignment of the sequences of the 20 members of the Group IA LodA-like 
proteins reveals that the residues which were mutated in this study are highly conserved 
in these sequences. Alignments of the regions of the sequence in which each of these 
three residues reside revealed that Cys448 (Table 3) and Lys530 (Table 4) are each 
conserved in each sequence. Tyr211 is conserved in 15 sequences and the other five 
have a Phe in this position (Table 5).  
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Table 3 Alignment of proteins in group IA. 
Around Cys448 in LodA, Blue, consensus 100%; Red, >90%; H, hydrophobic residue; 1, 
N or S 
*, IMG gene identification 
 
 
 
 
 
 
 
 
 
 
 
Locus tag Organism Sequence of residues 430-463 in LodA 
xhxxxDxxxhGNCVGxPxCPGIEVTWSxx1xxhY 
Marme_2662 LodA LodA Marinomonas 
mediterranea MMB-1 
PVSDMDTASIGNCVGLPMCPGIEMTWSLQNPVIY 
Mmwyl1_3721  Marinomonas sp. MWYL1 PVNEMDAASIGNCVGLPMCPGIEVTWSLQNSKLY 
M320_pool_00037300 Marinomonas sp GOBB3-320 YVNEMDAASIGNCVGLPMCPGIEVTWSLQNSKLY 
PTD2_20217   Pseudoalteromonas tunicata 
D2 
AVHPLDKASIGNCVGLPMCPGIEVTWSLQNPNLY 
G509DRAFT_1169  Flavobacterium subsaxonicum 
DSM 21790 
PVSLDDTASVGNCVGLPMCPGIEVTWSMQNPAVY 
PCIT_22609  Pseudoalteromonas citrea 
NCIMB 1889 
PVDPLDQGSVGNCVGLPMCPGIEVTWSLQNPKVY 
Rhein_1334   Rheinheimera sp. A13L PVNPLDQGSVGNCVGLPMCPGIEVTWSMQNPAVY 
H527DRAFT_03370  Aquimarina muelleri DSM 
19832 
AISEIDMASVGNCVGLPMCPGIEVTWSLQNENIY 
PL2TA16_00557  Pseudoalteromonas 
luteoviolacea 2ta16 
GVFYADQSSVGNCVGLPMCPGIEVTWSMQNPAVY 
PflaDRAFT_00041100 Pseudoalteromonas 
flavipulchra 2ta6 
GVFYADQGSVGNCVGLPMCPGIEVTWSLQNPAVY 
UY7DRAFT_03653  Pseudoalteromonas 
flavipulchra JG1 
GVFYADQGSVGNCVGLPMCPGIEVTWSLQNPAVY 
PPIS_19511  Pseudoalteromonas piscicida 
JCM 20779 
GVFYADQGSVGNCVGLPMCPGIEVTWSLQNPAVY 
G366DRAFT_02721  Pseudoalteromonas piscicida 
ATCC 15057 
GVFYADQGSVGNCVGLPMCPGIEVTWSLQNPAVY 
Gei7105DRAFT_0285  Geitlerinema sp. PCC 7105 GVDDRDRASVGNVVGLPQCPGIEVTWTTQNPIVY 
Nhal_1391  Nitrosococcus halophilus Nc4 PLCSATSAAMGNCVGLPMCPGIEVTWSMQNPAIY 
F460DRAFT_04769  Duganella zoogloeoides ATCC 
25935 
GIAALDRAAIGNCVGEPMCPGIEVTWSVRNPVIY 
2520384729* Nitrolancetus hollandicus Lb GIHPLDRVDIGNCVGDPMCPGIEVTWSVRNPAIY 
G559DRAFT_00896  Pseudomonas resinovorans 
DSM 21078 
GVTALDRASVGNCVGGPLCPGIEVTWSLYSPELY 
CC1582_00022990  Pseudomonas viriddaflava 
CC1582 
NVTDLDRASVGNCVGGPFCPGIEVTWSLYSKALY 
TA043_00024900  Pseudomonas viridaflava 
TA043 
NVTDLDRASVGNCVGGPFCPGIEVTWSLYSKALY 
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Table 4 Alignment of proteins in group IA. 
Around Lys530 in LodA, Blue, consensus 100%; Red, >90%; h: hydrophobic residue; 1, 
E or Q; 2, I or V; 3, S or T; 4, I or L 
*, IMG gene identification. 
 
 
 
 
 
Locus tag Organism Sequence of residues 494-590 in LodA 
xGC1PGDLTKRMAxPWQADFFxC32Qx2NFxxPxhN
K       PxxPxYYxYWWPPQSPWDV4 
Marme_2662  LodA Marinomonas mediterranea MMB-1 TGCEPGDLTKRMACPWQADFFNCTIQTVNFSEPSV
NK (x)40 PLPPAYYSYWWPPQSPWDVL 
Mmwyl1_372
1  
Marinomonas sp. MWYL1 VGCEPGDLTKRMACPWQADFFNCTVQVVNFSEPKV
NK (x)40 PLPPAYYSYWWPPQSPWDVL 
M320_pool_
00037300 
Marinomonas sp GOBB3-320 GGCEPGDLTKRMACPWQADFFNCTVQVVNFSEPK
VNK (x)40 PLPPAYYSYWWPPQSPWDVL 
PTD2_20217   Pseudoalteromonas tunicata D2 GGCQPGDLTKRMACPWQADFFQCTVQPVNFTEPLI
NK (x)74 PITPTYYSYWWPPQSPWDVL 
G509DRAFT
_1169  
Flavobacterium subsaxonicum DSM 21790 GGCEPGDLTKRMACPWQADFFECTIQTINFSDPAVN
K (x)08 PLPPTYYSYWWPPQSPWDVI 
PCIT_22609  Pseudoalteromonas citrea NCIMB 1889 GGCEPGDLTKRMACPWQADFFQCTIQNINFTNPAK
NK (x)04 PLPPTYYSYWWPPQSPWDVL 
Rhein_1334   Rheinheimera sp. A13L GGCQPGDLTKRMACPWQADFFQCTVQPVNFTVPE
VNK (x)04 PLPPTYYAYWWPPQSPWDVL 
H527DRAFT
_03370  
Aquimarina muelleri DSM 19832 GGCEPGDLTKRMACPWQADFFQCTIQYINFSDPEIN
K (x)34 PLPPSYYTYWWPPQSPWDVL 
PL2TA16_00
557  
Pseudoalteromonas luteoviolacea 2ta16 GGCQPGDLTKRMACPWQADFFNCTIQNVNFTDPTV
NK (x)12 PLAPTYYSYWWPPQSPWDVL 
PflaDRAFT_
00041100  
Pseudoalteromonas flavipulchra 2ta6 GGCQPGDLTKRMACPWQADFFNCTIQNVNFTEPTV
NK (x)12 PAAPTYYSYWWPPQSPWDVL 
UY7DRAFT_
03653  
Pseudoalteromonas flavipulchra JG1 GGCQPGDLTKRMACPWQADFFNCTIQNVNFTEPTV
NK (x)12 PAAPTYYSYWWPPQSPWDVL 
PPIS_19511  Pseudoalteromonas piscicida JCM 20779 GGCQPGDLTKRMACPWQADFFNCTIQNVNFTEPTV
NK (x)12 PAAPTYYSYWWPPQSPWDVL 
G366DRAFT
_02721  
Pseudoalteromonas piscicida ATCC 15057 GGCQPGDLTKRMACPWQADFFNCTIQNVNFTEPTV
NK (x)12 PAAPTYYSYWWPPQSPWDVL 
Gei7105DRA
FT_0285  
Geitlerinema sp. PCC 7105 GGCEPGDLTKRMAIPWQADFFNCSIQFVNFTDPNV
NK (x)09 PKPPTYYSYWWPPQAPWNVL 
Nhal_1391  Nitrosococcus halophilus Nc4 GGCEPGDLTKRMAIPWQADFFNCTIQYVNFTDPDIN
K (x)04 PLPPSYYAYWWPPQAPWDVL 
F460DRAFT
_04769  
Duganella zoogloeoides ATCC 25935 SGCEPGDLTKRMAIPWQADFYDCSVQMINFDNPDL
VK (x)06 PVPPTYYAYWWPPQSPWNVI 
2520384729* Nitrolancetus hollandicus Lb GGCEPGDLTKRMAIPWQADFFACSVQYINFTDPNV
NK (x)04 PKPPTFFAYWWPPQSPMHVI 
G559DRAFT
_00896  
Pseudomonas resinovorans DSM 21078 QGCEPGDLTKRMAIPWQADFFQCTVQYVNFTDPEV
NK (x)04 PKAPSYYAYWWPPQSPWNVL 
CC1582_000
22990  
Pseudomonas viriddaflava CC1582 QGCEPGDLTKRMATPWQSDFFQCTVQYINFSDSDA
NK (x)04 PKPPTYYAYWWPPQSPWNVI 
TA043_0002
4900  
Pseudomonas viridaflava TA043 QGCEPGDLTKRMATPWQSDFFQCTVQYINFSDNDA
NK (x)04 PKPPTYYAYWWPPQSPWNVI 
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Table 5 Alignment of proteins in group IA. 
Around Tyr211 in LodA, Blue, consensus 100%; Red, >90%; h: hydrophobic residue; 1, 
G or S; 2, Y or F; 3, G or A; 4, S or A 
*, IMG gene identification. 
 
Locus tag Organism Sequence of residues 182-230 in LodA 
LGxhxTDxxGRLhVhGGxGxAGGxxxhx123GxxxWxDDx4DGxVxC
xh 
Marme_2662  LodA Marinomonas 
mediterranea MMB-
1 
LGTLRTDSQGRLIVLGGYGFAGGNTDLSGYGGGDDWYDDISDGS
VTCVV 
Mmwyl1_3721  Marinomonas sp. 
MWYL1 
LGTLLTDDKGRLIVLGGYGRAGGNTDLEGYGGGDEWFDDISDGP
VTCVV 
M320_pool_00037300 Marinomonas sp 
GOBB3-320 
LGTLRTDNKGRLIVLGGYGRAGGNTDLEGYGGGDEWFDDISDGP
VTCVV 
PTD2_20217   Pseudoalteromonas 
tunicata D2 
LGTLKTDNKGRLIVFGGYGHAGGDEALTSYGGSDTWHDDTADGP
VYCEV 
G509DRAFT_1169  Flavobacterium 
subsaxonicum DSM 
21790 
LGNLLTDASGRLVVLGGYGNAGGNEPLTSYGGSSTWHDDISDGP
VYCTV 
PCIT_22609  Pseudoalteromonas 
citrea NCIMB 1889 
LGDLKTDNEGRLIVLGGYGHAGGDKPLVSYGGSDTWHDDIADGP
VYCTV 
Rhein_1334   Rheinheimera sp. 
A13L 
LGDLLTDDLGRLIVLGGYGNAGGDEPLTSYGGSNTWHDDISDGPV
YCTV 
H527DRAFT_03370  Aquimarina muelleri 
DSM 19832 
LGDLLTDDEGRLIVLGGYGHAGGNEPLTSYGGSNTWHDDISDGPV
YCTI 
PL2TA16_00557  Pseudoalteromonas 
luteoviolacea 2ta16 
LGNILTDNEGRLVVIGGFGNAGGNEPLESYGGADTWHDDIADGTV
YCTV 
PflaDRAFT_00041100  Pseudoalteromonas 
flavipulchra 2ta6 
LGDILTDNEGRLVVLGGKGNAGGNLPLESYGGADTWHDDIADGTV
YCTV 
UY7DRAFT_03653  Pseudoalteromonas 
flavipulchra JG1 
LGDILTDNEGRLVVLGGKGNAGGNQPLESYGGADTWHDDIADGT
VYCTV 
PPIS_19511  Pseudoalteromonas 
piscicida JCM 
20779 
LGDILTDNEGRLVVLGGKGNAGGNQPLESYGGADTWHDDIADGT
VYCTV 
G366DRAFT_02721  Pseudoalteromonas 
piscicida ATCC 
15057 
LGDILTDNEGRLVVLGGKGNAGGNQPLESYGGADTWHDDIADGT
VYCTV 
Gei7105DRAFT_0285  Geitlerinema sp. 
PCC 7105 
LGTLKTDSSGRLLVLGGFGKSGGDLPLSSYGGADTWYDDISDGSV
TCTI 
Nhal_1391  Nitrosococcus 
halophilus Nc4 
LGTIKTDREGRLLVLGAYGRAGGDEPITSYGGADTWYDDIADGPV
ECTV 
F460DRAFT_04769  Duganella 
zoogloeoides ATCC 
25935 
LGEMRTDSAGNLLVIGAYGRAGGIDPITGFGGGDTWNDDIADGPV
TATV 
2520384729* Nitrolancetus 
hollandicus Lb 
LGDLLTDADGRLLVLGGFGKAGGSEPITSFAGADTWHDDVSDGP
VSCKL 
G559DRAFT_00896  Pseudomonas 
resinovorans DSM 
21078 
LGEMRTDQQGRLLVLGGYGHAGGNQSITSFAGADGWHDDISDGP
VTCTL 
CC1582_00022990  Pseudomonas 
viriddaflava 
CC1582 
LGGVLTDNKGRLLVLGGYGHAGGDQSITSFAGADTWHDDTSDGP
VTCTL 
TA043_00024900  Pseudomonas 
viridaflava TA043 
LGGVLTDKKGRLLVLGGYGHAGGDQSITSFAGADTWHDDTSDGP
VTCTL 
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Discussion 
               Site-directed mutagenesis of residues in the substrate channel of LodA have 
demonstrated that Cys448, Tyr211 and Lys530 play multiple roles in regulating Km values 
of substrates, kcat and the extent of biosynthesis of the protein-derived CTQ cofactor. It 
may seem intuitively odd that the WT enzyme would have less CTQ formed than some 
LodA variants. However, the fact that certain mutations either decrease or increase the 
efficiency of LodB-dependent CTQ biosynthesis is significant. This means that, in addition 
to furthering our understanding of the functional roles of these residues in the activity of 
LodA, these results highlight the point that different evolutionary factors must be 
considered for enzymes which possess protein-derived cofactors. Residues present in 
the active site that may be optimal for catalytic efficiency may not be the best to participate 
in CTQ biosynthesis, and vice versa. While CTQ biosynthesis is catalyzed by another 
enzyme, the residues surrounding the nascent CTQ may play important roles in properly 
positioning the Cys and Trp residues for modification or substrate oxygen for insertion, or 
both. In this regard, it has been shown that the first modification in the biosynthesis of 
CTQ takes place auto-catalytically in the absence of LodB, and that some LodA residues 
are involved in that process128. 
              The residue which corresponds in structure to Cys448 in two other 
quinoproteins, the CTQ-containing QHNDH101 and the TTQ-containing MADH144, is a 
structurally conserved Asp residue. Mutation of this corresponding Asp in MADH affected 
the efficiency of MauG-dependent TTQ biosynthesis but had no effect on the catalytic 
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activity of the population of the isolated MADH with fully formed TTQ95. Consistent with 
the results of the MADH study, it can be concluded that the residue at this position, 
Cys448 in LodA, is not the active-site base that is involved in deprotonation of the lysine-
CTQ adduct during catalysis as the C448A mutation has no significant effect on kcat. 
However, in contrast to the results of the MADH, mutation of Cys448 in LodA to Ala did 
not result in decreased levels of CTQ biosynthesis. Furthermore, the C448D LodA 
mutation appears to have enhanced the efficiency of CTQ biosynthesis. This suggests 
that the native LodA is a mixed population in which some of the protein has incompletely 
synthesized CTQ and is inactive. Together with the previous study that showed a role for 
the corresponding Asp in TTQ biosynthesis in MADH, it appears that an Asp residue in 
this position is preferred for tryptophylquinone cofactor biosynthesis. However, for LodA 
the presence of Asp at this position is not optimal for catalysis. In particular, this mutation 
increases the Km for lysine 35-fold. Thus, the sub-optimal role in CTQ biosynthesis of 
Cys448 is more than compensated for by the greater catalytic efficiency of the enzyme.  
             Mutation of Tyr211 and its H-bonding partner Lys530 had significant effects on 
both kcat and Km values. As discussed earlier, Tyr211 is present on a mobile loop and it 
is possible that the H-bond to Lys530 could anchor it in place at certain times during the 
catalytic cycle. The aromatic character of residue 211 seems critical for activity since the 
Y211F LodA retains function, whereas Y211A LodA and Y211E LodA are inactive. The 
K530A and K530R mutations significantly increased the Km values for the substrates, 
particularly O2. For lysine is increased 13- and 29-fold, respectively while for O2 it 
increased 5- and 3.5-fold respectively. Since the loop containing Tyr211 was not 
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observed in the structure of the lysine-CTQ adduct of LodA [8] it may not be important in 
stabilizing that intermediate. It is possible that Tyr211 in concert with Lys530 could aid in 
O2 binding, or retention of O2 in the active site to poise it for action. This would be 
consistent with the hydrophobic nature of residue 211 being important. Interestingly, the 
K530A mutation significantly increased kcat. Since the rate-limiting step for the overall 
reaction catalyzed by LodA is not known, it is difficult to interpret this effect. Given the 
position of Lys530 in the active site, and the fact that mutations to Ala and Arg each 
enhance rather than eliminate activity, these results suggest that Lys530 is not playing a 
direct role in acid-base chemistry or nucleophilic attack during catalysis. However, it is 
possible that that it could control the rate of binding of one or both of the substrates, or 
release of one or more of the products. If the hydrogen-bond between Lys530 and Tyr211 
stabilizes the positions of these residues such that they impede the entry into or exit from 
the active site, then the removal of this blockage of the active site channel caused by the 
K530A mutation could possibly accelerate a rate-limiting product release step which could 
account for the increase in kcat. This would also be consistent with the large increases in 
the Km values that are caused by mutation of Lys530. In this sense the mobile loop which 
can be anchored by a hydrogen-bond between Tyr211 and Lys530 could act as a switch 
that regulates entry of substrates and exit of products to and from the active site.  
            A couple of points require consideration regarding the kinetic analysis of the LodA 
variants. As stated earlier, it was not possible to perform a detailed steady-state analysis 
in which both substrates were varied over an appropriate range of concentrations of each 
substrate. As such, it is an assumption that each variant obeys a ping-pong mechanism 
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as does WT LodA. For example, with some flavoprotein oxidases it may be possible for 
reoxidation of the cofactor to precede or follow the release of the oxidized product. 
However, in the case of LodA, the substrate forms a covalent adduct with CTQ (Figure 2) 
and it is difficult to imagine how these mutations could alter the kinetic mechanism to 
allow O2 to reoxidize the cofactor prior to release of the aldehyde product. It should also 
be noted that the mutations in this study involve residues with ionizable groups. It was 
previously shown12 that kcat for LodA exhibits a bell-shaped pH profile with a maximum at 
pH 7.5, implicating the involvement of at least two ionizable groups, and that the Km for 
lysine also varied in this range. As such, it was not possible to compare kinetic parameters 
in a pH-independent region.  
             These results reflect the different evolutionary factors that must be considered 
for enzymes which possess protein-derived cofactors. Since the catalytic cofactor must 
be generated by posttranslational modifications, this suggests that the protein must have 
originally evolved for some other purpose. The modifying enzyme likely also originally 
evolved for a different purpose. The residues in the active site could not have evolved to 
optimize function as a lysine oxidase until after the evolution of the LodA that led to its 
specific interaction with the modifying enzyme LodB and the ability to catalyze CTQ 
biosynthesis. This is well-described by the observation that some Y211A and Y211E 
mutations maximize levels of CTQ biosynthesis but are inactive in catalysis. Also 
consistent with this argument is the observation that Lys530 mutations lead to decreased 
CTQ biosynthesis but increased kcat. The fact that each of the mutations in this study 
increased Km values for lysine and O2 further indicate that the combination of residues 
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throughout the active site channel together participate in the specificity and catalytic 
efficiency of the enzyme. 
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CHAPTER 5: GLYCINE OXIDASE (GOXA) 
 
Introduction 
 
                LodA is a unique protein in itself as it is the first among the group of L-amino 
acid oxidases to be a quinoprotein instead of a flavoprotein. Upon further investigation it 
was discovered though that there was a complete new reservoir of LodA-like proteins 
containing CTQ cofactors. The only other CTQ containing protein that has been studied 
so far has been the QHNDH. But due to the complexity in its structure complete 
characterization was not possible. Of late a new protein from the same Marinomonas 
mediterranea was found to show glycine oxidase activity and has been referred to as 
GoxA. It is similar to LodA in a lot of aspects. Both have been found to contain 
tryptophylquinone (CTQ) cofactor instead of being flavoproteins like the other L-
aminoacid oxidases. The Cys and the Trp that are supposedly involved in the CTQ 
formation have been found to be conserved. Both the lodA and the goxA genes have a 
second gene lodB and goxB respectively present downstream which encodes proteins 
that are necessary for the mature CTQ generation. LodA and GoxA have been found to 
show 22.8% identity and 34.6% similarity (distribution in microbial genomes). A crystal 
structure of LodA has been reported but one for GoxA hasn’t been reported yet. Figure 
16 shows an overlay of the homology model of GoxA with the crystal structure model of 
LodA. The major differences lie in the type of amino acid that they use as substrates. 
LodA carries out the oxidative deamination of L-lysine whereas the GoxA catalyzes the 
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reaction for glycine. Upon phylogenetic and sequence analysis LodA and GoxA were put 
in 2 different groups. Group IA included the LodA and similar proteins and group II had 
the GoxA and similar proteins. Most of the proteins in Group II contain a twin arginine 
sequence. This is absent in the Group I LodA-like proteins indicating that there could be 
difference in the final translocation of the proteins which would thus have an effect on the 
overall function of each of these enzymes in the marine bacterium. A third protein has 
also been found from the same bacterium and has been thought to be LodA-like, but its 
function has not yet been discovered. This brings about an interesting observation. 
Marinomonas mediterranea encodes both LodA and GoxA. But based on the sequence 
and phylogenetic analysis they have been placed in different groups. This could be based 
on different enzymatic actions. Hence in order to study the diversity in the group of these 
unusual tryptophylquinone cofactor containing oxidases, GoxA was chosen as the second 
protein to study. By characterization of GoxA a better understanding could be obtained 
about the similarities and differences in the structure, function, mechanism of the reaction 
catalyzed. 
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Figure 16 Overlay of the homology model of GoxA with the model for the established 
crystal structure of LodA.  
Red – LodA, Blue – GoxA. 
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CHAPTER 6: INTERACTION OF GOXA WITH ITS MODIFYING ENZYMES AND ITS 
SUBUNIT ASSEMBLY ARE DEPENDENT ON THE EXTENT OF CYSTEINE 
TRYPTOPHYLQUINONE BIOSYNTHESIS 
Biochemistry, 2016, 55 (16), pp 2305–2308 
Introduction 
                Quinoproteins may contain exogenous quinone cofactors such as 
pyrroloquinoline quinone134 or protein-derived quinone134 cofactors that are formed by 
irreversible posttranslational modification of amino acid residues, most notably Tyr and 
Trp (Figure 17)6. Tyrosine-derived cofactors include trihydroxyphenylalanine (Topa) 
quinone (TPQ)57 which is found in several copper-containing amine oxidases53 and lysyl 
tyrosylquinone (LTQ) which is found in lysyl oxidase135. Tryptophan-derived cofactors 
include tryptophan tryptophylquinone (TTQ) which is found in amine dehydrogenases and 
cysteine tryptophylquinone (CTQ) which was been found in quinohemoprotein amine 
dehydrogenase (QHNDH)71, in an ε-lysine-epsilon oxidase (LodA)101 and in a glycine 
oxidase (GoxA)8.  
              The mechanisms of the biosynthesis of the protein-derived quinone cofactors 
differ from cofactor to cofactor14. For the Tyr-derived cofactors it is a self-processing event 
which is dependent on the presence of copper and O2. The copper facilitates oxygen 
insertion in the Tyr side chain and subsequently remains in the active site and assists in 
catalysis146, 147. The biosynthesis of TTQ in methylamine dehydrogenase (MADH) 
includes posttranslational modifications that are catalyzed by a diheme enzyme called  
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Figure 17 Protein-derived quinone cofactors formed by posttranslational modification. 
CTQ is cysteine tryptophylquinone cofactor. TTQ is tryptophan tryptophylquinone 
cofactor. TPQ is 2,4,5-trihydroxyphenylalanine quinone or Topaquinone. LTQ is lysine 
tyrosylquinone. 
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MauG72. The mechanism of the biosynthesis of CTQ in QHNDH has yet to be fully 
characterized, but it does require one or more other gene products8. In the case of LodA 
and GoxA it has been shown that flavoproteins are required for the biosynthesis of CTQ, 
although no mechanistic studies have been thus far reported. The posttranslational 
modifications required for CTQ biosynthesis are the incorporation of two oxygen atoms 
into the side-chain of a specific Trp residue and covalent cross-link formation between 
that residue and a Cys residue (Figure 17). LodA and GoxA were isolated from the marine 
bacteria, Marinomonas mediterranea71, 101. The gene clusters which encode LodA and 
GoxA each contain only one other gene, lodB and goxB89. Each of these genes is 
predicted to encode a putative flavoprotein. Expression of either active LodA or GoxA 
with the mature CTQ cofactor requires that lodA and goxA each be co-expressed with 
lodB and goxB, respectively124. Expression of either active lodA or goxA in the absence 
of lodB or goxB, respectively, leads to the production of inactive forms of the proteins that 
lack CTQ. These precursor proteins have been termed preLodA and preGoxA11. 
              This study reports the isolation and characterization of a complex of precursor 
GoxA and GoxB. It is shown that a flavin is indeed present in this complex with the 
putative flavoprotein, GoxB, and that mature CTQ is not present in the precursor form of 
GoxA. An active GoxA with mature, CTQ which is not in complex with GoxB, is also 
isolated from the same prep. Evidence is presented that the affinity between GoxA and 
GoxB is dependent upon the extent of CTQ biosynthesis. Furthermore, it is shown that 
the oligomerization state of GoxA is dependent on the extent of CTQ biosynthesis. These 
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results are compared and contrasted with the features of the biosynthesis of TTQ and 
TPQ in their respective enzymes. 
Materials and methods 
          GoxA and GoxB were expressed in E. coli Rosetta cells. The cells were 
transformed with the pET15GoxAB plasmid which contained goxA, to which a 
hexahistidine tag had been added and goxB downstream of goxA. The cells were grown 
in LB media which also contained ampicillin and chloramphenicol. Cells were grown at 
30˚C to an OD of 0.6. At that point 1 mM IPTG was added and after four hours cells were 
harvested. The harvested cells were sonicated in 50 mM potassium phosphate, pH7.5, 
and centrifuged. The supernatant was passed through a Ni-NTA affinity column. The 
column was washed using a gradient of imidazole in the same buffer. Protein eluted over 
a range of 30-150 mM imidazole. The eluted protein was dialyzed and again applied to 
the affinity column and the process was repeated using a narrower imidazole gradient to 
improve purity and to better separate the two fractions. As discussed in the results, two 
fractions were identified, one containing both GoxA and GoxB which eluted at lower 
imidazole concentration and one which contained GoxA alone that eluted at higher 
imidazole concentration.  
            Glycine oxidase activity was determined using a coupled enzyme assay which 
had been previously described101. The assay was performed under aerobic conditions at 
30˚C. In addition to the glycine substrate the assay mixture contained 20 U/ml glutamate 
dehydrogenase 5 mM 2-oxoglutarate and 0.25 mM NADH. The reaction was initiated by 
addition of 2 mM glycine. The ammonia generated by the oxidative deamination of glycine 
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(eq 1) was used as a co-substrate by glutamate dehydrogenase (eq 2) leading to the 
oxidation of NADH which accompanied by a decrease in absorbance at 340 nm (ε340 of 
NADH is 6220 M-1cm-1). 
glycine + O2 + H2O → glyoxylate + NH3 + H2O2      (6.1) 
2-oxoglutarate + NH3 + NADH → glutamate + H2O + NAD+              (6.2) 
            SDS-PAGE was performed by standard methods 7.5% gels. Gels were stained 
for protein with EZ protein gel staining solution. In order to perform the quinoprotein stain 
for detection of a covalent quinone proteins, without staining for protein, electrophoretic 
transfer of the proteins to a nitrocellulose membrane (0. 2µm pure nitrocellulose 
membrane, BioRad) was performed. This was done at 120 V for 1h at low temperature to 
prevent overheating. To stain for the presence of quinoproteins11, the nitrocellulose 
membrane was incubated for 45 min in the dark in a solution of 2 M potassium glycinate, 
pH 10, containing 0.24 mM Nitro Blue Tetrazolium71. The quinoproteins will stain. The 
nitrocellulose membrane was then washed and stored in 0.1 M sodium borate, pH 10.0 
until dried.  
            Size exclusion chromatography (SEC) was performed using a HiLoad 16/600 
Superdex 200 column (GE Healthcare). The buffer used for chromatography was 50 mM 
potassium phosphate buffer, pH 7.5, containing 150 mM NaCl. The flow rate was 0.6 
mL/min. Glutamate dehydrogenase (332 kDa), MADH (124 kDa), MauG (42 kDa) and 
amicyanin (11.5 kDa) were used as standards. Blue dextran was used to determine the 
void volume. Gaussian fits of the chromatogram (Prism Graph Pad) were used to resolve 
overlapping peaks in the chromatogram and integrate the areas under the peaks.  
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Results 
          During purification of the His-tagged recombinant GoxA, two protein fractions 
eluted from the Ni-NTA resin affinity column, one at approximately 60 mM imidazole and 
the other at approximately 100 mM imidazole. When assayed for glycine oxidase activity 
the first fraction exhibited no activity, whereas the second fraction was active and 
exhibited a kcat of 14.90 ± 0.02 s-1 under aerobic conditions (252µM O2) with 2 mM glycine 
concentration and 30˚C.. Each of the fractions exhibited a different visible absorption 
spectrum. That fraction that was active exhibited spectral features in the 350–420 nm 
range that are consistent with the presence of CTQ with peaks (Figure 18A). Similar 
visible absorbance spectra have been reported for LodA148 and the ε subunit of QHNDH13 
and a synthetic CTQ model compound105. In contrast, the inactive fraction exhibited as 
absorbance spectrum with features characteristic of a flavin. (Figure 18B). This suggest 
that the fraction contained GoxB, although that protein did not have a His-tag. From this 
spectrum it could not be concluded whether or not CTQ was also present as the 
absorbance of the flavin would mask the CTQ spectrum.  
           The two fractions were analyzed by SDS-PAGE (Figure 19A). The inactive fraction 
contained two species. The larger band migrated as expected for GoxA which has a 
predicted mass from the gene (Marme_1655) of 76284.8 Da. The other migrated as would 
be expected for GoxB which has a predicted mass from the gene (Marme_1654) of 
41856.3 Da. That active fraction contained only one major species which migrated as 
expected for GoxA. Analysis by mass spectrometry confirmed that the second species 
was exactly the molecular weight of the untagged GoxB. Unfortunately the intact GoxA  
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Figure 18 Visible absorption spectra of the two protein fractions that eluted from the Ni-
NTA affinity column. 
A. Absorption spectrum of the active fraction which exhibits a spectrum characteristic of 
CTQ. B. Absorption spectrum of the inactive fraction exhibits a spectrum characteristic of 
flavin. 
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species did not fly in the mass spectrometer and so it was not possible to determine from 
the mass whether or not CTQ was present in the GoxA in the inactive fraction which co-
eluted with GoxB. It was not possible to separate the two proteins in the inactive fraction 
by other chromatographic techniques. The sample was subjected to anion exchange 
(DEAE) chromatography, hydrophobic interaction chromatography using butyl sepharose 
and size exclusion chromatography. In each case the proteins co-eluted indicating that 
the two proteins interact with each other to form a tight complex.  
           Two possible reasons for the lack of activity in the fraction containing the GoxA-
GoxB complex are that either the presence of the second protein interferes with the 
reaction or the GoxA is actually a precursor lacking the mature CTQ cofactor. As the 
presence or absence of CTQ could not be confirmed by the absorbance spectrum or 
mass spectrometry analysis, an alternative was used to determine whether CTQ was 
present. The proteins were subjected to SDS-PAGE followed by electroblot to a 
nitrocellulose membrane which was subjected to a staining protocol that is specific for 
covalent quinoproteins148 (Figure 19B). The active GoxA that eluted by itself stained 
positive. The GoxA which co-eluted with GoxB did not stain indicating that it does not 
have the mature CTQ cofactor. Thus, it is actually the precursor GoxA. Additional proteins 
were included on the gel as positive and negative controls. Two proteins were included 
in which the presence of the quinone cofactor has been verified in crystal structures. 
MADH contains two subunits with TTQ present in the smaller subunit144. The smaller 
subunit stained positive and the larger one did not. LodA, which contains CTQ132 also 
stained positive.  
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Figure 19 SDS-PAGE and quinoprotein staining of protein fractions. 
Top. SDS gel stained for protein. Bottom. Western blot of a gel identical to that in A which 
was stained for quinoproteins.  The lane labeled GoxA is the active fraction gel stained 
for protein. The lane labeled GoxAB is the inactive fraction. The TTQ-bearing MADH and 
CTQ-bearing LodA were used as controls. 
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The GoxB present in complex with the precursor form of GoxA did not stain. Comparable 
amounts of GoxA, MADH, LodA, and the precursor GoxA-GoxB complex were loaded on 
the gel. GoxA and LodA did not transfer to the nitrocellulose as efficiently as the other 
proteins. For that reason the gel in Figure 19A, which is identical to the one which was 
used in the electroblot transfer to a nitrocellulose membrane was intentionally overloaded 
to ensure that a negative result was not because of insufficient transfer of proteins. For 
further confirmation a dot blot was performed in which the protein sample was spotted 
directly on the nitrocellulose membrane, dried and then subjected to the staining 
procedure. Again the active protein stained positive and the inactive did not, indicating 
that whereas the active GoxA has mature CTQ the GoxA in complex with GoxB does not 
(Figure 20) 
The inactive and active fractions were also characterized by size exclusion 
chromatography. The active GoxA with CTQ eluted from the column primarily as a dimer 
(Figure 21A). Two peaks were observed. The relative mass of the major peak (84%) was 
approximately 140 kDa and that of the minor peak (16%) was approximately 76 kDa which 
is the predicted molecular weight of the monomer. The inactive fraction containing 
precursor GoxA and GoxB eluted 100% as a single peak with a relative mass of 
approximately 120 kDa which is approximately the sum of the predicted molecular 
weights of GoxA and GoxB (Figure 21B).   
 The implications of these results are profound.  
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                                      A                             B                               C 
 
 
Figure 20 Dot Blot on nitrocellulose membrane. 
A. 8µg of GoxA stained positive for quinoprotein stain. B. 8µg of LodA stained positive for 
quinoprotein stain. C.8ug of precursor GoxA and GoxB complex which did not stain for 
the quinoprotein indicating the absence of a mature CTQ. 
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Figure 21 Size exclusion chromatography 
The active fraction containg GoxA (A) and the inactive fraction containing precursor GoxA 
and GoxB (B). The positions of elution and molecular weights of standards used to 
calibrate the column are indicated. 
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Together the results indicate that the GoxA precursor forms a tight complex with GoxB, 
whereas GoxA with mature CTQ does not. Thus, complex formation between the two is 
strongly dependent upon the extent of CTQ biosynthesis. Furthermore, the native dimeric 
structure of active GoxA is not achieved until after CTQ formation and release of GoxB. 
Thus, the oligomerization state of GoxA is also dependent upon the extent of CTQ 
biosynthesis. The latter point is in stark contrast to what was observed for TTQ 
biosynthesis in MADH by the diheme enzyme MauG. In that system it was shown that 
preMADH existed as a heterotetramer and formed a complex with two molecules of 
MauG, one associated with each halve of the heterotetramer88. Thus, in contrast to the 
results obtained for GoxA, the assembly of MADH showed no dependence on the extent 
of TTQ biosynthesis. 
  
Discussion 
The mechanisms of the biosynthesis of protein-derived cofactors are complex and 
diverse. The most common protein posttranslational modifications, such as 
phosphorylation and glycosylation, occur at the surface of the proteins enabling the 
substrate residues to directly contact the modifying enzyme. In contrast, the amino acid 
residues that undergo posttranslational modification reside within the protein. Some of 
these modifications are self-processing events. As discussed earlier, an example of this 
is the TPQ cofactor of copper-containing amine oxidases. In this case the host protein 
binds copper which is used to activate oxygen for insertion into the side-chain of a specific 
Tyr residue149 and then participates in catalysis142, 143. 
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The best characterized process of enzyme-catalyzed posttranslational 
modifications to form a quinone cofactor is the biosynthesis of the TTQ cofactor of MADH 
by the diheme enzyme MauG. It was shown that the oxidation of the residues of the 
precursor protein of MADH (preMADH) by a unique bis-FeIV high-valent state of the heme 
did not occur by direct reaction. Instead it required long range electron transfer from the 
substrate to the hemes through the protein by a hole-hopping mechanism of electron 
transfer. It was possible to crystallize a catalytically competent complex of preMADH and 
MauG. However the proteins did not form a stable complex in solution, as do precursor 
GoxA and GoxB. Kinetic studies demonstrated that the affinity of MauG for preMADH was 
approximately 10-fold greater than for MADH with mature TTQ, but the interactions were 
transient. In the present study difference in affinity of GoxB for the GoxA precursor protein 
is far greater than for the modified GoxA. In one case a complex forms which cannot be 
separated and in the other complex formation is undetectable. 
LodA which is also isolated from the same bacterium as GoxA also contains a CTQ 
cofactor. The biosynthesis of the cofactor is dependent upon the flavoprotein LodB. In 
contrast to what was observed with GoxA, no complex of preLodA or LodA with LodB was 
ever observed during purification. In fact, the preparation of pure LodA was found to 
contain preLodA as well which was clearly not in complex with LodB. Thus, while preLodA 
and LodB must interact to achieve CTQ biosynthesis, the complex formation between the 
two must be transient as was the case with preMADH and MauG, and different from what 
was observed for precursor GoxA-GoxB complex. The observation is also consistent with 
the previous observation that LodB and GoxB cannot substitute for each other and are 
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specific for their respective LodA and GoxA precursor proteins. It seems that it may not 
just be specificity but the mechanisms of action of LodB-dependent and GoxB-dependent 
CTQ biosynthesis may have significant differences. 
These results also demonstrate that CTQ formation in GoxA occurs prior to its 
forming its native dimeric state. This is in stark contrast to what was observed in the 
MADH-MauG system. This initial characterization of the tight complex formed by GoxA 
precursor and GoxB is an important step towards for future studies to characterize the 
details of the mechanism of CTQ formation by GoxB. As GoxB is a flavoprotein, this 
mechanism will likely describe novel reactions the catalysis of which are unprecedented 
for a flavin cofactor.   
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CHAPTER 7: GLYCINE OXIDASE (GOXA) PREPS FOR OPTIMIZING YIELDS OF 
THE PROTEIN 
Introduction 
             GoxA was being expressed by transforming into the Rosetta cells, the pET15 
plasmid vector containing the goxA and the goxB gene present on the same operon. 
These preps resulted in the formation of a small amount of the 2 different fractions of 
protein, the precursor GoxA-GoxB and the matured GoxA. In order to completely 
characterize an enzyme, its kinetic properties needed to be studied. Since the yield from 
these cultures were not satisfactory to carry out the studies, other constructs were made 
to see if the expression could be optimized. Table 6 shows the different constructs that 
were used to express more active GoxA. Different factors were considered for this.  
1. Co-expression of the proteins from genes on different plasmids could improve the 
yield. 
2. The GoxA genes all had N-terminal His tags with a few extra amino acid coding 
codons. His tags were engineered into the C-terminal end to ensure that the His 
tag on the N-terminal side wasn’t affecting the overall expression of the protein. 
Materials and methods 
             When 2 different plasmids were used with the goxA and the goxB gene 
separately, co-transformation was done in order to express the proteins. The 
pColADuetGoxA The Rosetta cells were grown and induced at 30˚C for 4hours. For the 
pColADuetGoxA + pET11GoxB His tagged, BL21 cells were used and grown passed 
through Ni-NTA columns for better separation.  
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Table 6 Plasmid vectors that were used for co-expression. 
1 was co-expressed with 2a and 2b separately. 
 
 
 
 
  
Vector type Constituting genes His-tag 
1. pColDuetGoxA GoxA gene including the 
leader sequence 
C-terminal  
2a. pETGoxB11 GoxB gene C terminal  
2b. pETGoxB11 GoxB gene No His tag 
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Results and discussion 
            The C-terminal goxA gene engineered into the pColADuet vector was co-
expressed with the C-terminal goxB gene containing pET11 vector and also with the 
untagged goxB in the pET11 vector. In both cases GoxA protein was expressed. But 
unlike the pET15 vector containing both goxA and goxB gene on the same operon, the 
overall yield of the protein was very low. The fact that the genes were not present on the 
same operon probably lead to an inefficient complex formation between the GoxA and 
the GoxB. Due to this essentially GoxA was generated with no or trace amounts of GoxB. 
Figure 22 shows an SDS gel picture with the corresponding combinations. Samples from 
the preps that used pET15 vector containing N-terminal His tagged GoxA was also run 
on the gel for comparison. Upon carrying out the activity assay for these fractions it was 
observed that they exhibited baseline levels of activity. This probably was due the weak 
or no heterodimer formation between the 2 proteins as seen in the last chapter. This also 
indicates the importance of the physical formation of the complex to facilitate the mature 
CTQ formation in GoxA. The yield too did not improve upon changing the tags from the 
N-terminal to the C-terminal. This indicated that the expression of matured CTQ 
containing GoxA was absolutely dependent on its formation of complex with GoxB. Hence 
having the 2 genes on 2 different operons did not optimize the expression condition. Once 
the CTQ has been generated the GoxB comes off and is replaced by a monomer of GoxA. 
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                  Lane:        1             2                3                 4              5 
 
Figure 22 SDS gel picture of the different GoxA expressions. 
Lane 1 – protein molecular weight markers, lane 2 – fraction containing precursor GoxA 
and GoxB complex expressed from the pET15 vector containing goxA and goxB gene on 
the same operon, lane 3 – fraction containing matured GoxA from the same prep. 
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CHAPTER 8: ROLES OF CONSERVED RESIDUES OF GOXAIN CONTROLLING 
GLYCINE OXIDASE ACTIVITY, COOPERATIVITY, SUBUNIT COMPOSITION AND 
CYSTEINE TRYPTOPHYLQUINONE BIOSYNTHESIS 
Introduction 
The glycine oxidase (GoxA)14 is the second enzyme to be isolated from the 
melanogenic marine bacterium, Marinomonas mediterranea which bears the protein-
derived cysteine tryptophylquinone (CTQ) cofactor6, 150. The first such enzyme was the 
lysine-ε-oxidase (LodA)8. The biosynthesis of the CTQ cofactor of each enzyme requires 
posttranslational modifications that are catalyzed by a specific flavoenzyme, GoxB or 
LodB, respectively124, 151. In each case, the gene clusters contain only two genes, goxA 
and goxB, and lodA and lodB. In addition to the interesting features of the biosynthesis of 
CTQ in these enzymes, they exhibit atypical activities. All other known tryptophylquinone 
enzymes that contain either CTQ or tryptophan tryptophylquinone (TTQ) are 
dehydrogenases6, 150, whereas GoxA and LodA are oxidases. The current study 
characterizes the steady-state kinetic properties of GoxA and variants generated by site-
directed mutagenesis. Despite the similarities of GoxA and LodA, the results reveal that 
the kinetic mechanisms of the two enzymes and roles of conserved active-site residues 
are quite different. 
LodA catalyzes the oxidative deamination of side-chain of L-lysine to generate a 
semialdehyde, ammonia and H2O2 as products 8. The enzyme is secreted, and as a 
consequence of the H2O2 generation exhibits antimicrobial properties that lead to 
dispersal and differentiation of the biofilm in which the host bacterium resides 10. Steady-
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state kinetic analysis using its substrates, lysine and O2, showed that LodA follows a ping-
pong kinetic mechanism involving a Schiff base intermediate formed between the ε-amino 
group and CTQ152. This was verified by crystal structure of LodA with the lysine-CTQ 
adduct formed132. Roles of residues in and around the active-site of the LodA in catalysis 
and CTQ biogenesis were identified by site directed mutagenesis13. 
            GoxA catalyzes the oxidative deamination of glycine to generate a glyoxylate, 
ammonia and H2O2 as products 14. Whereas LodA exhibited typical Michaelis-Menten 
behavior, the current steady-state kinetic study of GoxA reveals that it exhibits allosteric 
cooperativity towards the glycine substrate. It was previously shown that purified active 
GoxA eluted primarily as a dimer during size-exclusion chromatography 153. As the crystal 
structure of GoxA has yet to be determined, a homology model is constructed from the 
GoxA sequence and the LodA structure. Given the observed cooperativity and dimeric 
structure, a docking model is also constructed in which the GoxA monomer is docked with 
itself to form a putative dimer. The docking model predicts that the entrances to the active-
site of each of the two monomers are in the proximity of the protein-protein interface.  
Phylogenetic analysis of the Integrated Microbial Genomes database of genome 
sequences 125 revealed that LodA-like proteins can be clustered in five different groups 
that were detected in several classes of bacteria and fungi. LodA is among proteins 
classified as Group I LodA-like proteins and GoxA is present in Group II. Comparison of 
the sequences of the Group I and Group II proteins with the structure of LodA and the 
homology model of GoxA revealed candidates to target for site-directed mutagenesis 
(Figure 1). Of particular interest was Phe237. Whereas all Group II proteins have a Phe 
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in this position of the sequences, most Group I proteins including LodA have a Tyr in this 
position. It is demonstrated herein that mutation of Phe237 to Tyr or Ala eliminates the 
cooperativity exhibited by GoxA, and weakens dimer formation. His466 was of interest 
because all Group II proteins each have His in this position, which is in proximity of CTQ 
in the active-site, while the Group I proteins all have a Cys at the corresponding position. 
Asp547 which also resides near CTQ was also of interest as this residue is conserved in 
all Group I and Group II proteins as well as all other structurally characterized TTQ-
dependent and CTQ-dependent enzymes 154-156. These results presented herein provide 
insight into the roles of specific active-site residues in catalysis and CTQ biogenesis, as 
well as describing an interesting mechanism by which a single residue can dictate 
whether or not an enzyme exhibits cooperative allosteric behavior towards a substrate. 
Materials and Methods 
Construction, expression and purification of GoxA and its variants 
Wild-type (WT) GoxA and GoxA variants that were generated by site-directed 
mutagenesis were expressed by co-expression of the goxA gene with goxB in E. coli 
Rosetta cells as described previously 153. The GoxA proteins possessed a 6XHis tag 
which was engineered into the gene. Preparation of cells extracts and purification using 
a Ni-NTA affinity column was performed as previously described 153. The following 
mutations were made: D547A, H466A, H466D, H466C, F237A and F237Y. The forward 
and reverse primers that were used are listed in Table 7. Using these primers the 
mutations were incorporated by PCR using the QuikChange Lightning kit (Agilent).  
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Table 7 Primers used for site-directed mutagenesis 
 
 
 
 
 
 
 
 
 
 
Mutations                             Primers 
H466A 
 
Forward - 5´GCATTCGCCCCTGGCGTCG 3´ 
Reverse - 5´CGACGCCAGGGGCGAATGC 3´ 
H466D 
 
Forward - 5´ GGCGCATTCGATCCTGGCGT 3´ 
Reverse - 5´ ACGCCAGGATCGAATGCGCC 3´ 
H466C 
 
Forward - 5´ GGCGCATTCTGTCCTGGCGTC 3´ 
Reverse - 5´GACGCCAGGACAGAATGCGCC 3´ 
F237A 
 
Forward - 5´ GCTATTACGAGTGCCGCCGATAACGAT 3´ 
Reverse - 5´ ATCGTTATCGGCGGCACTCGTAATAGC 3´ 
F237Y 
 
Forward - 5´ GCTATTACGAGTTACGCCGATAACGAT 3´ 
Reverse – 5´ ATCGTTATCGGCGTAACTCGTAATAGC 3´ 
D547A Forward - 5´ TGGCAGTGTGCGGCCTTCAG 3´ 
Reverse - 5´ CTGAAGGCCGCACACTGCCA 3´ 
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Steady-state kinetic analysis  
GoxA was assayed using a coupled enzyme assay in which the formation of the 
NH3 product (eq 1) is monitored by coupling its production to the reaction of glutamate 
dehydrogenase (eq 2). The standard assay mixture contained GoxA, 5 mM 2-
oxoglutarate, 0.25 mM NADH, and 20 U/ml glutamate dehydrogenase at 30˚C. The 
reaction was initiated by the addition of glycine. The initial velocity was determined by 
monitoring the rate of disappearance of NADH at 340 nm using the ε340 of NADH of 6220 
M-1cm-1. Initial rates were determined in the presence of varying amounts of glycine and 
O2. To vary [O2], a stock solution of the buffer was made anaerobic by repeated cycles of 
vacuum and purging with argon and then mixed anaerobically with an appropriate amount 
of either air saturated buffer ([O2]= 252 µM) or 100% O2-saturated buffer ([O2]= 1150 µM) 
buffer 145. 
Glycine + O2+ H2O → glyoxylate + NH3+ H2O2      (7.1) 
NH3 + 2-oxoglutarate + NADH    L-glutamate + H2O + NAD+  (7.2) 
Two alternative equations were used to fit the data from the kinetic experiments. 
In the Michaelis-Menten equation (eq 3) kcat is turnover number for the protein, Km is the 
Michaelis-Menten constant, [S] is the substrate concentration, [E] is the enzyme 
concentration and v is the initial reaction rate. In the Hill equation (eq 4) K0.5 is the 
concentration of the substrate that produces half the maximal velocity, and h is the Hill 
coefficient. 
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v/[E] = kcat[S]/(Km+[S])                                                                                        (7.3) 
v/[E]= kcat[S]h/ (K0.5)h + [S]h)                                                                               (7.4) 
Size exclusion chromatography  
Size exclusion chromatography was performed with an AKTA Prime FPLC system 
using a HiLoad 16/600 Superdex 200 (GE Healthcare). Chromatography was performed 
in 50 mM potassium phosphate buffer plus 150 mM NaCl at pH 7.5. The flow rate was 
0.6 mL/min. The void volume was calculated using blue dextran. Proteins used as 
molecular weight markers were a mixture containing glutamate dehydrogenase (332 
kDa), methylamine dehydrogenase (124 kDa), MauG (42 kDa) and amicyanin (15 kDa). 
A plot of the elution volume/void volume versus log molecular weight was used to estimate 
the masses of the WT and variant GoxA proteins. Gaussian fits of the chromatogram 
(using Origin and graphed in Prism Graph Pad) were used to resolve overlapping peaks 
in the chromatogram and integrate the areas under the peaks. 
Construction of homology and docking models 
A homology model of GoxA was constructed with the sequence of goxA gene 
(Marme_2396) and the structure of LodA (PDB 2YMW) using the SWISS-MODEL tool at 
www.swissmodel.expasy.org 157. A docking model of the putative GoxA dimer was 
constructed by using the ZDOCK utility at http://zdock.umassmed.edu 158. A PDB file 
generated from the homology model was docked against itself.  
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Results 
Steady-state kinetic analysis of WT GoxA 
Initially the concentration of the glycine was varied in the presence of 100% O2-
saturated (1150 µM) buffer. Initial rates were measured and the data were fit to the 
Michaelis-Menten equation (eq 3) (Figure 23A). While the fit was reasonably good 
R2=0.97, the error ranges were high (kcat = 56 ± 5 s-1 and Km = 999 ± 172 µM) and a 
systematic deviation to the fit was evident (i.e., data points clustered above and below 
the fitted curve). The data were then fit to the Hill equation (eq 4) (Figure 23B) and a much 
improved fit was obtained (R2=0.99). All data points now fall on the fitted curve. The 
analysis yield values of kcat = 39±2 s-1 and K0.5 = 514 ± 42 µM. The fit also yielded a Hill 
coefficient of 1.7 ± 0.2, indicative of positive cooperativity. Given the previous finding that 
GoxA is a homodimer 153, the h value of 1.7 is consistent with a kinetic mechanism in 
which the binding of the first glycine molecule to one subunit enhances the affinity of the 
second subunit for glycine. Next the concentration of O2 was varied in the presence of a 
saturating concentration of glycine (5 mM). In this case the data were fit well by the 
Michaelis-Menten equation (Figure 23C) and no improvement of the fit was obtained by 
using the Hill equation (Figure 23D). Thus, GoxA does not exhibit cooperative behavior 
towards O2, but only towards glycine. The analysis of the data using eq 3 yielded values 
of kcat = 93 ± 18 s-1 and Km = 2590 ± 690 µM.  
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Figure 23 Steady-state kinetic analysis of GoxA. 
Assays of glycine oxidase activity were performed with varied concentrations of glycine 
in the presence of a fixed concentration of 1150 µM O2 (A and B) or with varied 
concentrations of O2 in the presence of a fixed concentration of 5 mM glycine (C and D). 
The lines are fits of each data set by either eq 3 (A and C) or eq 4 (B and D). 
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    A couple of points are noteworthy. These results indicate that the Km for O2 is 
actually greater than the [O2] in a 100% O2 saturated solution, and much greater than in 
air-saturated buffer. For this reason the assays were repeated anaerobically in the 
presence of alternative small molecule electron acceptors to see whether GoxA could 
function as a dehydrogenase. However, no activity was observed when replacing O2 with 
NAD+, ferricyanide, phenazine ethosulfate or dichlorophenolindophenol. Also, the kcat 
obtained when varying O2 was 93 s-1 compared to 39 s-1 when varying glycine. The reason 
for this is that the fixed concentration of O2 that was used, which is the highest that can 
be achieved, was not a saturating concentration (i.e. was not much greater than the Km 
for O2). Thus, the lower value is an apparent kcat determined at sub-saturating 
concentration of the fixed substrate, and the value of 93 s-1 determined by varying O2 at 
a true saturating concentration of glycine is a more valid estimation of the true kcat. 
Because of the cooperative behavior towards glycine and the inability to achieve 
saturating concentrations of O2, it was not possible to perform the experiments in which 
both substrates could be varied over the appropriate range of concentrations necessary 
to determine whether or not GoxA obeys a ping-pong mechanism, as was done with LodA 
152. 
Structural comparisons of GoxA with LodA 
The crystal structure of GoxA has not yet been determined but it was possible to 
construct a homology model of the structure based on its sequence and the crystal 
structure of LodA (Figure 24A). Alignment of the homology model of the structure of GoxA 
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with LodA reveals strong structural conservation of the active sites (Figure 24B). It shows 
that the CTQ cofactor in GoxA is formed from Cys551 and Trp566. These residues were 
previously shown by proteolysis and mass spectrometry of GoxA to form CTQ 11, thus 
supporting the validity of the model. For reasons discussed earlier, Asp547, His466 and 
Phe237 of GoxA were chosen as candidates for site-directed mutagenesis to elucidate 
structure-function relationships.  Phe237 is of interest because it corresponds in 
sequence to Tyr211 of LodA, which is conserved in most Group I proteins and which 
strongly influenced the Km values of both lysine and O2 for LodA 13. In the homology model 
the position of Phe237/Tyr211 is not structurally conserved as are the positions of CTQ 
and the other two residues. Furthermore, in LodA Lys530 forms a hydrogen bond with 
Tyr211, but no Lys is present in this position in GoxA.  
Effects of site-directed mutagenesis on active-site residues of GoxA 
Asp547. Mutation of Asp512 in LodA affected CTQ biosynthesis and so its effect on the 
activity of the mature enzyme could not be assayed 11. The analogous D547A mutation 
was made in GoxA. This resulted in protein with no activity. Furthermore, the inactive 
protein was isolated primarily in complex with the modifying enzyme GoxB. It was 
previously shown that a precursor of WT GoxA which lacks CTQ forms a tight complex 
with GoxB 153. Thus, Asp547 in GoxA must also be play a role in CTQ biosynthesis on 
GoxA. 
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Figure 24 Overlays of the homology model of GoxA with the crystal structure of 
LodA (PDB ID 2YMW). 
(A) The overall structures of monomers of LodA (green) and GoxA (orange) are 
superimposed. (B) The active sites of GoxA and LodA are superimposed. The Cys and 
Trp residues which form CTQ and selected other residues are shown as stick. Carbons 
on residues of LodA and GoxA are colored green and orange, respectively. Oxygen is 
colored red, nitrogen blue and sulfur yellow. 
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His466. His466 corresponds to the Cys448 of LodA. That residue was mutated to Ala, 
Asp and His 13. No stable C448H LodA protein was isolated, suggesting that the mutation 
affected the biosynthesis or stability of the protein, or both. C448A LodA and C448D LodA 
could be isolated. Those mutations had little effect on kcat but each increased the Km 
values for both lysine and O2 13. The corresponding H466C, H466A and H466D mutations 
were made in GoxA. As described above for D547A GoxA, each of these three variant 
proteins could only be isolated in a complex with GoxB and exhibited no activity. Thus, it 
appears that His466 is also important for GoxB-dependent CTQ biosynthesis in GoxA. 
As such, the roles His466 and Asp547 in catalysis by GoxA could not be studied, as the 
mutations compromised CTQ biosynthesis. 
Phe237. Phe237 corresponds to the Tyr211 of LodA. That residue was mutated to Phe 
and Ala. Y211A LodA was inactive and Y211F LodA exhibited a decreased kcat and 
significantly increased Km for both lysine and O2 13. Phe237 in GoxA was converted to Tyr 
and Ala. The F237Y GoxA variant protein was isolated and assayed. As with WT GoxA, 
activity was measured at varied concentrations of the glycine in the presence of O2-
saturated (1150 µM) buffer. In contrast to what was observed for WT GoxA, the data for 
F237Y GoxA did fit well to the Michaelis-Menten model (Figure 25A). No improvement of 
the fit was obtained using the eq 4 and the fit to that equation yielded a Hill coefficient 
value of approximately 1. This indicates that the cooperativity towards glycine exhibited 
by WT GoxA is lost as a consequence of the F237Y mutation.  
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Figure 25 Steady-state kinetic analysis of GoxA variants. 
Assays of glycine oxidase activity of F237Y GoxA were performed with varied 
concentrations of glycine in the presence of a fixed concentration of 1150 mM O2 (A) or 
with varied concentrations of O2 in the presence of a fixed concentration of 5 mM glycine 
(B). Assays of glycine oxidase activity of F237A GoxA were performed with varied 
concentrations of glycine in the presence of a fixed concentration of 1150 mM O2 (C) or 
with varied concentrations of O2 in the presence of a fixed concentration of 5 mM glycine 
(D). The lines are fits of each data set by either eq 3.  
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Table 8 Steady-state kinetic parameters for GoxA and GoxA variant proteins 
 
 
 
aTaken from reference 12. 
bkcat values are from the experiments in which O2 was varied rather than from studies 
where  glycine was varied since it was not possible to achieve saturating concentration 
of O2 
cWT GoxA fit best to eq 4 and so the K0.5 value is used rather than a Km value. 
 
 
 
 
 
 
 
 
 
 
 
 WT GoxA F237Y GoxA F237AGoxA  LodAa 
  kcat (s-1)b 93 ± 18    15 ± 5  0.6 ± 0.1 0.22 ± 0.04 
K0.5 glycine (µM) 514 ± 42c        -        -          - 
Km glycine (µM)        -   3030 ± 840  826 ± 123 - 
Km lysine (µM) - - -   3.2 ± 0.5 
Km O2 (µM) 2600 ± 693   2270 ± 1000  416 ± 157   37.2 ± 6.1  
kcat/KmO2 (M-1s-1)     36000         6600      1000       5900 
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Activity was also assayed by varying the concentration of O2 in the presence of a 
saturating concentration of glycine (Figure 25B).Comparison of the fitted values of the 
kinetic parameters (Table 8) indicates that the F237Y mutation decreased kcat and 
increased Km for glycine with little effect on the Km for O2. The F237A GoxA variant protein 
was also isolated and analyzed (Figure 25C and D). This variant also obeyed Michaelis-
Menten kinetics without cooperativity towards glycine. The fitted values of the kinetic 
parameters (Table 8) indicate that this mutation substantially reduced kcat, had little effect 
on the Km for glycine, and substantially decreased the Km for O2. Thus, Phe237 not only 
dictates cooperative behavior towards glycine but also influences the kcat and Km values 
for both glycine and O2. 
Effects of Phe237 mutations on the oligomerization state of GoxA 
In order to determine whether mutations of Phe237 which abolished cooperativity 
also affected the stabilization of the native homo-dimeric state of GoxA, the WT and 
variant proteins were analyzed by size exclusion chromatography. WT GoxA (Figure 26A) 
elutes from the column primarily as a dimer. One observes a minor peak at about 76 kDa 
(16%) which corresponds to the predicted mass of a monomer and a major peak at 
approximately 140 kDa (84%). In contrast, the majority of F237Y GoxA (Figure 26B) 
elutes as a monomer with a major peak at 76 kDa (62%) and a minor peak at 140 kDa 
(38%). The majority of F237A GoxA (Figure 26C) also elutes as a monomer with a major 
peak at 76 kDa (68%) and a minor peak at 140 kDa (32%).  
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Figure 26 Size exclusion chromatography 
WT GoxA (A), F237Y GoxA (B) and F237A GoxA (C). The positions of elution of molecular 
weight marker proteins are indicated. 
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A docking model of the GoxA dimer 
In order to gain insight into how Phe237 might be involved in the cooperativity and 
stabilization of dimer formation, a protein docking model was constructed using the 
ZDOCK program (Figure 27). Interestingly, it shows the Phe237 resides at the protein-
protein interface and that the Phe237 residues of each subunit are in close proximity to 
each other when present as a dimer. Phe237 is also in a position in which it may interact 
with other aromatic amino acids residues that are present at the interface, Tyr618 and 
Trp619. In fact, the Tyr618 residues of the two monomers are at a distance of 1.7 Å from 
each other. The inter-subunit distance between the Trp691 residues of each monomer is 
about 4 Å. The aromatic residues being in such close proximity suggests the possibility 
of π-stacking between the side-chains. Since the model used to estimate the distances 
between these residues is a homology model, the values thus obtained are approximate. 
However, π-stacking interactions between residues would likely induce the other amino 
acids to rearrange themselves. Thus, these residues may be important in the stabilization 
of the dimeric structure and the communication between the two active sites that results 
in the observed cooperativity of WT GoxA.   
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Figure 27 Docking model of the GoxA monomers to form a dimer structure. 
The two monomers are colored blue and pink respectively. (A) The overal structure of the 
dimer with residue Phe237 shown in stick. (B) An expanded view of the protein-protein 
interface of the two monomers. The Cys and Trp residues which form CTQ and selected 
residues at the interface are shown as stick. Carbons on residues of LodA and GoxA are 
colored blue and pnik, respectively. Oxygen is colored red, nitrogen blue and sulfur yellow 
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Discussion 
GoxA and LodA are CTQ-containing oxidases discovered in the same bacteria, M. 
mediterranea. Each of them belongs to a new class of unusual tryptophylquinone 
cofactor-containing oxidases. Analysis of the Integrated Microbial Genomes database of 
genome sequences identified 168 genes from 144 different species that encode LodA-
like proteins 125. Prior to the characterization of LodA and Gox, all known quinoprotein 
oxidases contained a tyrosylquinone cofactor 159, and in general all amino acid oxidases 
contained a flavin cofactor160. Despite the similarities in sequence and structure exhibited 
by GoxA and LodA, there are interesting differences in their kinetic mechanisms and 
steady-state kinetic parameters. This could be a consequence of different physiological 
roles of the proteins. LodA is a secreted protein which exhibits antimicrobial activity that 
is important for the health of the biofilm in which the host bacterium resides 10. GoxA has 
also been reported to exhibit antimicrobial activity, however the finding of cooperativity 
towards glycine and production of glyoxylate, which is an important metabolite161, 
suggests a possible metabolic and regulatory functions.  
GoxA exhibits cooperative behavior towards its glycine substrate whereas LodA 
exhibits no cooperativity. The Km values for glycine and O2 for GoxA are each much 
greater than for LodA, however the kcat value of GoxA is also much greater than that for 
LodA. Thus, despite the very large Km value which GoxA exhibits for O2, the catalytic 
efficiency kcat/KmO2 for GoxA is actually six-fold greater than that of LodA (Table 2). Thus, 
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LodA seems to have evolved its catalytic efficiency by increasing affinity for substrates, 
which GoxA has improved its catalytic efficiency by increasing kcat. 
 Asp547 and His466 of GoxA appear to be critical for CTQ biosynthesis. The 
corresponding Asp512 in LodA was also shown to be critical for CTQ biosynthesis, while 
certain substitutions of Cys448 of LodA, which corresponds to His466, were tolerated 13. 
The tolerated mutations did, however, significantly increase the Km value for lysine and 
altered the efficiency of CTQ biosynthesis. These results for the CTQ-dependent 
enzymes are reminiscent of those from studies of TTQ biosynthesis in MADH 162. The 
active site of that enzyme has Asp in each of these two corresponding positions, Asp76 
and Asp32. Mutation of the Asp76 that corresponds in position to Asp547 in GoxA 
resulted in production of only trace amounts of protein which lacked TTQ. Mutation of the 
Asp32 which corresponds in position to His466 in GoxA resulted in isolation of a mixed 
population in which some protein was active, albeit with significantly decreased affinity 
for substrate, and some lacked TTQ 162. This highlights the fact that these active site 
residues which likely play roles in catalysis or substrate binding, or both, must have 
previously evolved to facilitate the process of CTQ biosynthesis. 
 The protein interface of the GoxA dimer predicted from the modeling studies 
is completely different from what was observed in the crystal structure of LodA 132. LodA 
crystallized as a tetramer. Each LodA monomer has an unusual structure with two arms 
of antiparallel β-strands extended from the main body of the subunit. These extensions 
participate in subunit interactions.  The primary sequence of this structural feature of LodA 
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is not present in GoxA, consistent with it exhibiting a different subunit composition and 
different subunit-subunit interactions. 
The importance of Phe237 of GoxA in stabilizing subunit-subunit interactions and 
dictating cooperative behavior towards glycine is remarkable. The F237Y and F237A 
mutations each eliminated cooperativity towards glycine. However, the F237Y mutation 
decreases kcat about six-fold and decreases KmO2 slightly, while the F237A mutation 
decreases kcat 155-fold and decreases KmO2, six-fold (Table 4.4.2). Despite the 
differences in the effects on the kinetic parameters of substitution with Ala versus Tyr, the 
destabilization of the dimer by the F327A mutation is only slightly greater than for the 
F237Y mutation (Figure 4). This indicates that activity is not strictly dependent upon dimer 
formation. This also means that F327 of GoxA exerts a significant influence on the kcat 
and affinity for substrates as does Tyr211, the corresponding residue in LodA. In LodA 
the Y211A mutation eliminated activity while the Y211F mutation caused a small 
decrease in kcat but a large increase in Km for lysine 13. 
At this point one can only speculate on the mechanism by which Phe237 stabilizes 
dimer formation and is involved in the communication between subunit active sites that 
results in cooperativity. As discussed earlier, the docking model suggests the possibility 
that strong π-interactions and π-stacking involving Phe237 and surrounding aromatic 
residues could be involved in these processes. A different structural role for Phe237 in 
GoxA than for Tyr211 in LodA is also consistent with the absence of a residue that 
corresponds to Lys530 in LodA. The crystal structure of LodA suggested that Tyr211, 
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which resides on a flexible loop near the entry to the substrate channel, formed a 
hydrogen bond with Lys530 creating a gate-like structure to control entry and exit of 
substrate and the products from the active site. Because of the absence of hydrogen bond 
to the corresponding Phe237, the corresponding loop in GoxA and consequently Phe237 
adopts a different position (Figure 5) which now involves protein-protein interactions.  
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CHAPTER 9: CONCLUSION 
                This study involves the structural and functional characterization of two 
oxidases, LodA and GoxA originally found in the same bacterium, Marinomonas 
mediterranea. They are unique as they are the first reported examples of 
tryptophylquinone cofactor containing oxidases. Both of them contain CTQ and carry out 
oxidative deamination of amino acids, L-lysine and glycine respectively. Steady state 
kinetic analysis of LodA and GoxA showed difference in their mode of reaction catalysis. 
GoxA displayed allosteric cooperativity for glycine whereas LodA did not for its substrate, 
L-lysine. The cooperativity of GoxA was supported by the presence of the enzyme as a 
dimer. Regulation of substrate interaction was also different in the two proteins. In LodA 
it occurred by the gate-like formation generated by the H-bonded Lys530 and Y211. In 
GoxA it occurred by the dimer formation mediated by Phe237. Thus the kinetic and site-
directed mutagenesis studies have revealed the possibility of two different physiological 
functions of LodA and GoxA in the microorganism, one being antimicrobial and the other 
being metabolic, respectively. 
                  Various key points have been identified in this study. Site-directed 
mutagenesis has shown the importance of a single amino acid residue in stabilizing the 
structure and conformation of an enzyme. It has also highlighted another very significant 
aspect regarding the evolution of these enzymes. It is evident that they have been 
optimized for their functions but not essentially for selectivity, activity and cofactor 
generations as some mutants did show better CTQ formation than the wildtype, but ended 
up having compromised or no activity. The kinetic studies have also shown how enzymes 
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with similar cofactors but different physiological functions could maximize their catalytic 
efficiencies by merely adjusting kinetic parameters like kcat and Km. Most importantly since 
this has been the first detailed structural and functional analysis of CTQ containing 
oxidases, it will help in broadening the horizon of understanding posttranslational 
modifications of amino acids in quinoproteins. 
            In future this study could help in characterizing similar CTQ containing proteins 
which have been discovered recently as constituting a whole new pool of 
tryptophylquinone cofactor containing oxidases. The biosynthesis of CTQ cofactor has 
not yet been well characterized. The mutagenesis studies have already implicated the 
importance of certain amino acid residues in the CTQ biosynthesis process. Furthermore, 
the isolation of the complex of the two proteins one of which catalyzes the cofactor 
formation and the other being in a precursor form will help in determining the mechanism 
of cofactor biogenesis. Another interesting aspect would be to study the flavoproteins, 
LodB and GoxB. No flavoprotein has yet been reported to catalyze a quinone cofactor 
formation. Characterizing these will help in identifying the similarities and differences with 
the already reported flavoproteins that function as oxidases and catalyze redox reactions. 
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